CARAMEL COLOURS EXPLANATION In the period since 1972, when the fifteenth report of the Committee was published (Annex 1, reference 26), caramel colours have been classified into 4 classes which differ in their method of manufacture, composition, functional properties, and application. 1. Caramel Colour I (synonyms: plain caramel, caustic caramel, and spirit caramel); this class is prepared by the controlled heat treatment of carbohydrates with alkali or acid. 2. Caramel Colour II (synonyms: caustic sulfite process caramel); this class is prepared by the controlled heat treatment of carbohydrates with sulfite-containing compounds. 3. Caramel Colour III (synonyms: ammonia caramel, ammonia process caramel, closed-pan ammonia process caramel, open-pan ammonia process caramel, bakers' caramel, confectioners' caramel, and beer caramel); this class is prepared by the controlled heat treatment of carbohydrates with ammonium compounds. 4. Caramel Colour IV (synonyms: ammonia sulfite process caramel, sulfite ammonia caramel, sulfite ammonia process caramel, acid-proof caramel, beverage caramel, and soft-drink caramel); this class is prepared by the controlled heat treatment of carbohydrates with ammonium-containing and sulfite-containing compounds. Caramel colours were reviewed at the eighth, thirteenth, fifteenth, sixteenth, eighteenth, twenty-first, and twenty-fourth meetings of the Committee (Annex 1, references 8, 19, 26, 30, 35, 44, & 53). The thirteenth meeting concluded that a toxicological distinction between caramels produced commercially and caramel formed in cooked foods or when sucrose is heated is unwarranted except with caramel prepared by processes using ammonia or ammonium salts. This conclusion was endorsed by the fifteenth meeting and an ADI "not limited" was allocated to caramel colours prepared by processes other than those involving ammonia or ammonium salts; a temporary ADI of 0-100 mg/kg b.w. was allocated to caramel colours produced by the ammonia process. The sixteenth meeting reviewed further information on the composition of caramel colours produced by the ammonia process, including the 4-methylimidazole content. Revised specifications were prepared and the previously-established temporary ADI was maintained. The specifications for this class were further revised by the eighteenth meeting and the temporary ADI was extended pending the results of long-term and reproduction studies on caramel colours prepared by the ammonia or ammonia sulfite process. The twenty-first meeting of the Committee noted that the specifications for caramel colour (ammonia process) were ambiguous, since they appeared to cover caramel colours manufactured by the ammonia sulfite process as well. Separate specifications were prepared for caramel colour (ammonia process) and caramel colour (ammonia sulfite process), which have since been designated caramel colours III and IV, respectively. The two classes have been shown to differ in toxicity. The principal toxic effect of caramel colour III is depression of circulating lymphocytes and leucocytes, and a no-effect level could not be determined; accordingly, the temporary ADI was revoked. The temporary ADI of 0-100 mg/kg b.w. was retained for caramel colour IV pending the submission of reports of adequate carcinogenicity/teratogenicity studies. The twenty-fourth meeting extended the temporary ADI for caramel colour IV and confirmed that caramel colour II had no ADI since it was not included in the ADI for caramel colour I nor the temporary ADI for caramel colour IV. Since the previous evaluations, additional data have become available and are summarized and discussed in the following monographs. Previously-published monographs have been expanded and are reproduced in their entirety under the class of caramel colour to which they relate. CARAMEL COLOUR I EXPLANATION At the thirteenth and fifteenth meetings (Annex 1, references 19 & 26), the Committee concluded that caramel colour I is a natural constituent of the diet and is acceptable as an additive. An ADI "not limited" was allocated at the fifteenth meeting. BIOLOGICAL DATA Biochemical aspects No information available. Toxicological studies Special study on mutagenicity Two samples of caramel colour I with different colour intensities were subjected to the Ames test using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, and TA1538. Caramel colour I was neither mutagenic nor cytotoxic, either with or without activation by rat liver S-9 fraction, at concentrations up to 20 µl per plate (Richold & Jones, 1980a,b). Acute toxicity No information available. Short-term studies Rats Caramel colour I was administered to groups of 20 weanling female Wistar rats at dietary levels of 0, 15, or 30% for 8 weeks followed by a 4-week recovery period. Diarrhoea was observed in the treated animals and food efficiency was decreased, but the growth rate was normal. Haematological indices, in particular leucocyte counts, were normal throughout the study. The relative caecal weights were increased after eight weeks, but returned to normal by the end of the 4-week recovery period. Discolouration of the mesenteric lymph nodes was observed in animals of both treatment groups after eight weeks, but the discolouration diminished during the recovery period. No other gross or microscopic pathological changes were reported (Sinkeldam & van der Heyden, 1976). Long-term studies No information available. Observations in man No information available. Comments Caramel colour I is free of the heterocyclic compounds associated with convulsant activity or depressed lymphocyte counts which occur in caramels prepared using ammonia or ammonium salts, and displays a low order of short-term toxicity. None of the data suggest a need to revise earlier JECFA recommendations. EVALUATION Estimate of acceptable daily intake for man ADI "not specified". REFERENCES Richold, M. & Jones, E. (1980a). Ames metabolic activation test to assess the potential mutagenic effect of ETA-38-2H. Unpublished report No. FDC 8/80359 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Richold, M. & Jones, E. (1980b). Ames metabolic activation test to assess the potential mutagenic effect of ETA-38-1W. Unpublished report No. FDC 8/80361 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J. & van der Heyden, C.A. (1976). Short-term feeding test with three types of caramels in albino rats. Unpublished report No. R4789 from CIVO/TNO, Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. CARAMEL COLOUR II EXPLANATION The twenty-fourth meeting of the Committee (Annex 1, reference 53) drew attention to the fact that caramel colour II has no ADI since it is not included in the ADI of caramel colour I. This material has not previously been evaluated by the Committee. BIOLOGICAL DATA Biochemical aspects No information available. Toxicological studies Special studies on mutagenicity Caramel colour II at concentrations of 2.5-20 µl/plate was neither mutagenic nor cytotoxic in the Ames test using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, and TA1538, with or without metabolic activation by rat liver S-9 fraction (Richold & Jones, 1980). In a similar test, caramel colour II was neither mutagenic nor cytoxic at concentrations of 50-5000 µg/plate (Richold et al., 1984). Caramel colour II was tested for potential mutagenic activity based on induction of DNA repair (unscheduled DNA synthesis) in cultured human epithelial (HeLa 53) cells. Caramel colour II was incorporated in the culture medium at concentrations of 25-51,200 µg/ml and the test was performed on 2 occasions both in the presence and absence of rat liver S-9 mix. In both tests, in the absence of the S-9 mix a small but statistically significant increase in the number of silver grains over nuclei was observed at a concentration of 25,600 µg/ml; no significant increases were seen at higher concentrations in this test nor at any concentration in the repeat test (Allen & Proudlock, 1984). Caramel colour II was not clastogenic to cultured Chinese hamster ovarian cells at concentrations of 500, 2500, or 5000 µg/ml either in the presence or absence of rat liver S-9 mix (Allen et al., 1984). Acute Toxicity No information available. Short-term studies Rats Five groups of 20 male and 20 female weanling Fischer F-344 rats were given caramel colour II in drinking water at dose levels of 0, 4, 8, 12, or 16 g/kg b.w./day for 90 days. Body weights and food and water intakes were recorded weekly. Haematological examinations, blood bichemical studies, and urinalysis were performed during the seventh week and at termination on all animals. Animals were fasted overnight prior to bleeding from the orbital sinus under anaesthesia; the animals were also fasted during the 24-hour urine collection period. At necropsy, organs were weighed and all animals were examined macroscopically. Histopathological examinations were conducted on all animals in the control and high-dose groups and on animals from the low- and mid-dose groups that died or were sacrificed in extremis. All animals showed a weight loss and reduced food intake between weeks 7 and 8, presumably due to the fasting prior to bleeding and during urine collection. In addition, caramel colour II caused a dose- related reduction in body-weight gain and in food and fluid intake in both sexes. Males treated with 8 g caramel colour II per kg b.w., and females treated with 4 and 8 g/kg b.w., had significantly lower food consumption than controls for 4 of 13 weeks, 3 of 13 weeks, and 6 of 13 weeks, respectively; mean food consumption, of both males and females treated with 12 and 16 g/kg b.w., was significantly lower than food consumption of their respective controls. All treated groups had lower mean fluid intake than their respective controls, usually significantly lower. Males receiving 12 and 16 g/kg b.w. had significantly lower mean body weights than controls from weeks 7-13 and weeks 4-13, respectively. Females treated with 8 g/kg b.w. had significantly lower mean body weights than controls from week 11-13 while, beginning at week 7, females receiving 12 and 16 g/kg b.w. had lower mean body weights than controls. Occasional statistically-significant changes were seen in some haematological and clinical chemical parameters, but the mean values were within the normal range for Fischer 344 rats and were not considered to be of toxicological significance. There was a dose- related reduction in urinary volume and pH, and an increase in urine specific gravity. At necropsy, treatment-related increases were observed in kidney weights and in full and empty caecum weights, but no significant histopathological changes were observed in these or other tissues. Dose-related staining of the gastrointestinal tract and mesenteric lymph nodes was noted, and deposits of yellow pigment were seen histopathologically in the caecal submucosa and mesenteric lymph nodes of the top-dose groups (the only treated animals examined comprehensively). Reactive hyperplasia was not associated with the pigment deposition. The investigators concluded that the reduced body weights, food and fluid intakes, and increased kidney weights were due to water imbalance reflecting poor palatability of the drinking solution rather than toxic effects of caramel colour II per se (MacKenzie, 1985). Comments The above data are insufficient to evaluate caramel colour II for an ADI, but the substance has a low sub-chronic toxicity and no frankly pathological effects were seen in the 90-day study. EVALUATION Estimate of acceptable daily intake for man No ADI allocated. REFERENCES Allen, J.A., Brooker, P.C., Birt, D.M., & McCaffrey, K.J. (1984). Analysis of metaphase chromosomes obtained from CHO cells cultured in vitro and treated with caramel colour (II). Unpublished report No. ITC 3A/84965 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Allen, J.A., & Proudlock, R.J. (1984). Autoradiographic assessment of DNA repair in mammalian cells after exposure to caramel colour II. Unpublished report No. ITC 2A/84750/2 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. MacKenzie, K.M. (1985). 90-day toxicity study of caramel color (caustic sulfite process) in rats. Vols. I & II. Unpublished report No. 6154-105 from Hazleton Laboratories America Inc., Madison, WI, USA. Submitted to WHO by International Technical Caramel Association. Richold, M. & Jones, E. (1980). Ames metabolic activation test to assess the potential mutagenic effect of ETA-38-3N. Unpublished report No. FDC 8/80356 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Richold, M., Jones, E., & Fenner, L.A. (1984). Ames metabolic activation test to assess the potential mutagenic effect of caramel colour II. Unpublished report No. ITC 1A/84708 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. CARAMEL COLOUR III EXPLANATION In earlier evaluations, the presence of 4-methylimidazole in caramel colour III was noted, particularly since this compound was likely to be the causal agent of convulsions in cattle and sheep fed ammonia-treated molasses. However, at its twenty-first meeting, the Committee (Annex 1, reference 44) no longer considered this a cause for concern since the introduction of chemical specifications limits the concentration of 4-methylimidazole in caramel colour III. The twenty-first meeting identified the principal toxic effect of ammoniated caramels as the depression of circulating lymphocytes and total leucocytes for which a no-effect level had not been determined; consequently, the temporary ADI for caramel colour III was revoked. BIOLOGICAL DATA Biochemical aspects Absorption, distribution, and excretion In groups of 2-4 rats, the absorption of the colour-giving components of caramel was determined by faecal extraction. Recoveries varied widely for the 10 or 20% caramel solutions examined despite pre-treatment for 100 days before testing. About one-third of the colour-giving components appeared to be absorbed, but no conclusions could be drawn regarding the absorption of colourless components (Haldi & Wynn, 1951). Toxicological studies Special study on 4-methylimidazole (4-MeI) 4-MEI has been shown to be the most likely toxic component in ammoniated molasses, its being a convulsant to rabbits, mice, and chicks at oral doses of 360 mg/kg b.w. (Nishie et al., 1969). Mice Male albino mice (20-25 g) were used to determine the median convulsive dose (CD50) and the median lethal dose (LD50) of a few imidazoles. The results are given in the following table: Convulsant and lethal effects of imidazoles CD50±SE LD50±SE in mg/kg in mg/kg b.w. b.w i.p oral b.w. i.p oral 4-methylimidazole 155 ± 5 360 ± 18 165 ± 3 370 ± 15 1-methylimidazole 380 ± 8.2 1,400 ± 79 380 ± 8.2 1,400 ± 79 2-methylimidazole 500 ± 12 1,300 ± 70 480 ± 18 1,400 ± 114 imidazole 560 ± 34 1,800 ± 45 610 ± 7.4 1,880 ± 45 All the imidazoles tested produced varying degrees of tremor, running, restlessness, dialorrhea, Straub tail, opisthotonus and tonic extensor seizure that ended in death (Nishie et al., 1970). Chickens The CD50 and the LD50 of 4-MEI by i.p. injection in 1-day-old chicks were 174±10 mg/kg b.w. and 210±15 mg/kg b.w., respectively. Orally, the CD50 was 580±30 mg/kg b.w. and the LD50 was 599±50 mg/kg b.w. Doses of 100 mg/kg b.w. i.p. caused tremors, peeping, and spreading of the wings. Doses over 150 mg/kg b.w. i.p. caused opisthotonus, prostration with clonic leg movements, and terminal tonic extensor seizure (Nishie et al., 1970). Special studies on reduction of total lymphocyte counts Following the request in the twenty-first report of the Committee for information on the factor(s) responsible for the haematological effects of caramel colour III, a series of studies have been performed to investigate the mechanism(s) underlying these effects and the agent(s) responsible. Rats The effects of vitamin E, folic acid, pyridoxine and choline on the capacity of caramel colour III to reduce total lymphocytes in the blood of rats fed caramel colour III were examined. Four groups of 10 male weanling rats were fed Spratt's diet containing 8% caramel colour III and supplemented with vitamin E (100 mg/kg), folic acid (10 mg/kg), pyridoxine hydrochloride (10 mg/kg), or choline chloride (1000 mg/kg). Groups on Spratt's diet alone or on Spratt's diet with 8% caramel colour III without any supplement were used as controls. After 12 days, there was a marked reduction in total white blood cells and lymphocytes in rats fed the diet containing 8% caramel colour III and neutrophil counts were increased. Dietary supplementation with vitamin E, folic acid, or choline did not noticeably affect lymphocyte counts. However, rats receiving the diet supplemented with pyridoxine had white blood cells and lymphocytes in numbers similar to those fed the basal diet without caramel colour III. The basal diet was found to contain 2.3 mg/kg pyridoxine. In a further study using CIVO stock diet (pyridoxine concentration 3 mg/kg), rats receiving 8% caramel colour III in the diet showed a reduction in total white blood cell and lymphocyte numbers; these changes were ameliorated by the addition of 10 mg/kg pyridoxine in the diet. In this study, neutrophils were not affected by the caramel colour III treatment, but the plasma pyridoxal phosphate levels were reduced by treatment (Sinkeldam et al., 1984). In order to quantify the relationship between dietary pyridoxine and reduction of lymphocyte counts by caramel colour III, and to study the effects of age, two 14-day studies were performed, one in weanling, and the second in mature, Wistar rats; in other respects the protocols were identical. Groups of 10 male animals were fed diets containing approximately 2.5, 6, 12, or 24 ppm of pyridoxine. At each dietary level groups were given caramel colour III1 in the drinking water at levels of 0, 1, 4, or 8%. A clear inverse dose relationship between the severity of lymphocyte depression and the pyridoxine level of the diet was observed. In weanling rats fed a diet containing 2.5 ppm pyridoxine, statistically significant lymphocyte reduction occurred at all caramel colour III levels on days 6 and 13. Groups fed diets containing 6, 12, or 24 ppm pyridoxine did not show statistically significant reductions in lymphocyte counts on day 6. However, on day 13, groups receiving 4 or 8% caramel colour III and 6 ppm pyridoxine in the diet had a statistically significant reduction in lymphocytes. On day 13 at a dietary level of 12 ppm pyridoxine only the 8% caramel colour III group had a statistically significant reduction in lymphocytes. There were no significant reductions in lymphocyte counts in animals fed 24 ppm pyridoxine at any level of caramel colour III intake. In mature rats fed 4 and 8% caramel colour III a statistically significant reduction in lymphocytes occurred at dietary pyridoxine levels of 12 ppm and lower on day 6. On day 13 lymphocytes were significantly decreased at caramel colour III doses 1, 4, and 8% in animals fed a diet containing 2.5 ppm pyridoxine. There were no significant decreases in lymphocytes at these dose levels of caramel colour III in animals fed 6, 12, or 24 ppm pyridoxine (Sinkeldam, 1981; 1982a). 1 This sample of caramel colour III contained 107 mg/kg 2-acetyl-4(5)-tetrahydroxybutylimidazole (THI) on a colour equivalent basis, 204 mg THI/kg on an 'as is' basis, and 295 mg THI/kg on a solids basis. Special studies on 2-acetyl-4(5)-tetrahydroxybutylimidazole (THI) An isolation procedure was developed and a fraction of caramel colour III that contained the lymphocyte-depressing activity was isolated. The single component of this fraction that was responsible for the activity was identified as THI (Kroplien et al., 1984). Rats THI was administered to groups of 10 male weanling Wistar rats at levels of 0, 2, 5, or 20 ppm in drinking water for 7 days; a fifth group received a 1% solution of caramel colour III in drinking water as a positive control. THI produced a marked depression of lymphocyte counts at all dose levels and a dose-dependent increase in neutrophils. The lymphocyte-depressing potency of 2 ppm THI was comparable to that of 1% caramel colour III in the drinking water, indicating a level of approximately 200 mg/kg THI in the caramel sample. This compares with the result of chemical analysis of a sample of this batch of caramel colour III, which indicated a value of 204 mg/kg THI on an 'as is' basis (Sinkeldam, 1982b; Kroplien, 1984). Special studies on carcinogenicity (see also long-term studies) Mice Three groups of 50 male and 50 female B6C3F1 mice were given drinking water containing 0, 1.25, or 5% caramel colour III for 96 weeks followed by 8 weeks of drinking water without caramel colour; the animals were fed CFR diet ad libitum. The caramel colour III used in this study contained less than 25 mg/kg THI. The animals were observed daily for abnormalities and mice showing signs of ill-health were isolated to be returned to the group if their condition improved but otherwise killed and autopsied. Individual body weights were recorded weekly for the first 14 weeks, then every-other-week. Food and water consumption were recorded over a 2-day period before each weighing. During week 104, fresh urine samples were obtained from all survivors and analysed for pH, protein, glucose, bilirubin, ketones, occult blood, and urobilinogen. At termination the animals were killed by exsanguination under ether anaesthesia and haematological examinations were performed, which consisted of measurements of haemoglobin concentrations, haematocrit values, erythrocyte counts, leucocyte counts, platelet counts, and differential leucocyte counts. At autopsy, gross findings were recorded and the following organs weighed: brain, heart, liver, spleen, adrenals, and testes or ovaries. Samples of these organs and of the salivary gland, trachea, lungs, thymus, lymph nodes, stomach, small intestine, pancreas, urinary bladder, pituitary, thyroid, prostate, seminal vesicle, uterus, mammary gland, skeletal muscle, eye, Harderian glands, spinal cord, sciatic nerve, and any other tissues of abnormal appearance were examined histologically (haematoxylin- and eosin-stained). Histopathological examinations were also performed on mice that died and on those that were killed in moribund condition. During the in-life phase no consistent differences were noted between the test and control groups with respect to growth or water intake. The cumulative mortality of males given 5% caramel colour III was higher than that of controls from week 100 to the end of the experiment, but there were no clear pathological differences in any organs and no treatment-related abnormalities in urinalyses. The only statistically significant differences in haematological parameters between control and treated groups were elevations of the total leucocyte counts in males of both treatment groups, but the observed values were within the range encountered for the strain of B6C3F1 mice used in the study. No treatment-related gross pathology was noted during or at the end of the experiment. Malignant lymphoma/ leukaemia, hepatocellular carcinoma, and sub-cutaneous fibrosarcoma and/or malignant fibrous histocytoma were frequent, but no significant differences were found in their incidences between treated and control groups. Adenomas and adenocarcinomas of the lungs, hyperplastic nodules of the liver, and fibroma of the sub-cutis were frequent in males, but their incidences were similar in treated and untreated mice. The authors concluded that, under the conditions used, caramel colour III was not carcinogenic for B6C3F1 mice (Hagiwara et al., 1983). Rats Three groups of 50 male and 50 female F344 rats were given caramel colour III in drinking water at levels of 0, 1, or 4% for 104 weeks followed by drinking water without caramel for 9 weeks. The animals were fed ad libitum basal diet that contained 11-12 mg/kg pyridoxine, and the caramel colour III used contained less than 25 mg/kg THI. During the experimental period, all animals were observed daily, and clinical signs and mortality were recorded. Body weights were recorded weekly during the first 13 weeks of the study and then every 4 weeks. Moribund or dead animals and animals sacrificed at termination were autopsied and examined for the development of tumours in the following organs and tissues: brain, pituitary, thyroid (including parathyroid), thymus, lungs, trachea, heart, salivary glands, liver, spleen, kidneys, adrenals, tongue, oesophagus, stomach, duodenum, jejunum, ileum, caecum, colon, rectum, urinary bladder, lymph nodes, pancreas, gonads, accessory genital organs, mammary gland, skin, musculature, peripheral nerve, spinal cord, sternum, femur, eyes, ear duct, and nasal cavity. These tissues were also examined histologically (haematoxylin- and eosin-stained). No treatment-related differences in growth or survival rates were noted. No dose-related effects were found either in the incidence or induction time of tumours in the various organs and tissues except in the pituitary gland of males of the top-dose group in which the incidence of tumours was significantly higher than that in controls. However, pituitary tumours are among the most common spontaneous tumours in F344 rats that occur with variable incidence; most of the tumours were microscopic and there were no significant differences in their induction times compared with controls. The authors concluded that the higher incidence of pituitary tumours was not related to caramel administration, but could be explained by the variability of spontaneous tumour incidence (Maekawa et al., 1983). Special studies on mutagenicity Caramel colour III (a blend of 3 commercial samples) was evaluated by the Ames Salmonella/microsome plate test and the Saccharomyces/microsome plate test. The Salmonella test organisms used were TA98, TA100, TA1535, TA1537, and TA1538; the Saccharomyces was strain D4, and the tests were conducted in the presence and absence of liver S-9 mix from Araclor-induced rats. The dose range employed was 1-50 mg/plate for TA100 and 1-20 mg/plate for all other test strains. Caramel colour III was non-mutagenic to the test organisms under these conditions (Jagannath & Brusick, 1978a). In a similar study using the same Salmonella tester strains, caramel colour III was non-mutagenic in a range of concentrations up to 20 µl/plate with or without metabolic activation (Richold & Jones, 1980). Caramel colour III was non-mutagenic in the Ames test against Salmonella strains TA98 and KTA100 at concentrations of 0-1 mg/plate, with or without metabolic activation. Acidic and basic organic extracts of the caramel were also non-mutagenic (Ashoor & Monte, 1983). Thirteen commercial caramel colours (not identified) were examined for mutagenicity in the Ames test, using Salmonella strains TA98 and TA100 with and without metabolic activation, and for DNA-damaging effects in E. coli (Wild/pol A-, Wild/rec A-); none of the samples tested was active under the test conditions (Kawana et al., 1980). Five samples of commercial caramel colour (not identified) were tested for mutagenicity in the Ames test using Salmonella strains TA98 and TA100. All samples gave equivocal results with TA100 and 2 of the 5 samples were equivocal with TA98 (Kawachi et al., 1980). Five samples of caramel colour were tested in the Ames Salmonella plate assay using strains TA98, TA100, and TA1537 without metabolic activation but with a 20-minute preincubation step. The same samples were used in chromosome aberration tests performed on a cultured Chinese hamster lung fibroblast cell line, both in the presence and absence of S-9 fraction. All samples of caramel colour were designated as positive both in the Ames assay and in the chromosome aberration test (aberrations in 20% of metaphase cells) (Ishidate & Yoshikawa, 1980). The same series of caramel colour samples was tested by Jagannath and Brusick, and all were found to be non-mutagenic in the Ames test using Salmonella strains TA98, TA100, TA1535, TA1537, and TA1538, and Saccharomyces strain D4, in the presence or absence of S-9 mix. One of the samples in this study and in the Ishidate & Yoshikawa (1980) study was caramel colour III (Jagannath & Brusick, 1978b). The mutagenicity of a series of samples taken at various stages in the manufacture of caramel colour III were assayed in the Ames test using Salmonella strains TA98, TA100, and TA1535, with and without metabolic activation. No mutagenicity was seen with any sample against all three tester strains in the presence of S-9 fraction but and increased number of revertants was found with strain TA100 in the absence of S-9 fraction. Mutagenic activity was associated with samples taken late in the process (Jensen et al., 1983). A sample of caramel colour III was non-mutagenic in the Ames test against Salmonella strains TA98, TA100, TA1535, TA1537, and TA1538 both in the presence and absence of rat hepatic S-9 fraction at caramel colour concentrations up to 5 mg/plate (Richold et al., 1984). The same sample as that used by Richold et al. (1984b) was tested for potential mutagenic activity based on induction of unscheduled DNA synthesis in cultured human epithelial (HeLa 53) cells both in the presence and the absence of rat liver S-9 fraction. The test was performed on two occasions at caramel colour III concentrations of 25-51,200 µg/ml in the culture medium. In both tests, caramel colour III caused a significant increase in the number of silver grains found over cell nuclei at concentrations of 6,400 and 12,800 µg/ml in the absence of S-9 mix; significant increases were not observed at higher or lower concentrations in the absence of S-9 mix nor at any of the concentrations tested in the presence of S-9 mix. The authors concluded that, although reproducible effects on unscheduled DNA synthesis were demonstrated in the test, this effect may be moderated by metabolism (Allen & Proudlock, 1984). Caramel colour III was not clastogenic to cultured Chinese hamster ovarian cells at concentrations of 500, 2500, or 5000 µg/ml either in the presence or absence of rat liver S-9 mix (Allen et al., 1984). The clastogenicity of caramel colour III was evaluated in an in vitro cytogenetic assay using cultured Chinese hamster ovarian cells. A significant increase in chromosome aberrations was observed at concentrations of 3 mg/ml or higher in the absence of metabolic activation; similar findings were reported for sodium ascorbate at 2 mg/ml (Galloway & Brusick, 1981a). These tests were repeated in the presence of rat liver S-9 fraction, and neither caramel colour III at a concentration up to 5 mg/ml nor sodium ascorbate at a concentration of 5 mg/ml was active (Galloway & Brusick, 1981b). In an in vivo mouse micronucleus test, caramel colour III was administered by gavage to 5 males and 5 females at doses of 0, 1.05, or 3.5 g/kg b.w. (2 doses 24 hours apart). Caramel colour III did not increase the incidence of micronuclei in polychromatic erythrocytes obtained from marrow and was considered by the authors not to exhibit clastogenic activity under the conditions of the test (Cimino & Brusick, 1981). Special studies on teratogenicity Teratogenicity studies were carried out on caramel colour III in mice, rats, and rabbits. The doses employed were 0, 16, 74.3, 345, and 1600 mg/kg b.w. in all three species. Mice Caramel colour III was administered by gavage to groups of 22 or 23 pregnant CD1 mice at the above doses beginning on day 6 and continuing through day 15 of gestation. On day 17, all dams were subjected to Caesarian section under anaesthesia and the numbers of implantation sites, resorption sites, and live and dead foetuses were recorded. The urogenital tract of each dam was examined for anatomical abnormalities and all foetuses were examined grossly for external abnormalities. One-third of the foetuses from each litter were examined for visceral abnormalities using the Wilson technique, and the remaining two-thirds were examined for skeletal defects after clearing and staining with Alizarin Red. Caramel colour III had no clearly discernible effects on nidation nor on maternal or foetal survival. The number of abnormalities of either soft or skeletal tissues of the test groups did not differ from those occurring spontaneously in controls (Morgareidge, 1974). Rats Caramel colour III was administered by gavage to groups of 21-24 pregnant Wistar rats at the above doses beginning on day 6 and continuing daily through day 15 of gestation. On day 20, all dams were subjected to Caesarian section under anaesthesia and the numbers of implantation sites, resorption sites, and live and dead foetuses were recorded. The body weights of live pups were also recorded. All foetuses were examined grossly for external abnormalities. One-third of the foetuses from each litter were examined for visceral abnormalities using the Wilson technique, and the remaining two-thirds were examined for skeletal defects after clearing and staining with Alizarin Red. Caramel colour III had no clearly discernible effect on nidation nor on maternal or foetal survival. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from those occurring spontaneously in controls (Morgareidge, 1974). Rabbits Caramel colour III was administered by gavage to groups of 11 or 12 pregnant Dutch-belted female rabbits at the above doses beginning on day 6 and continuing daily through day 18 of pregnancy. On day 29, all does were subjected to Caesarian section under anaesthesia and the numbers of corpora lutea, implantation sites, resorption sites, and live and dead foetuses were recorded. All foetuses were examined grossly for the presence of external congenital abnormalities. The live foetuses from each litter were then placed in an incubator for 24 hours for evaluation of neonatal survival. Surviving pups were sacrificed and all pups examined for visceral abnormalities by dissection. All foetuses were then cleared and stained with Alizarin Red and examined for skeletal defects. Caramel colour III treatment had no effect on nidation nor on maternal or foetal survival. The number of abnormalities in either soft or skeletal tissues of the test groups did not differ from those occurring spontaneously in controls (Morgareidge, 1974). Acute toxicity LD50 Species Route (mg/kg b.w.) Reference Rat oral > 2.3 ml approx. or eq. 1,900 Foote et al., 1958 Rat oral > 25 ml approx. or eq. 17,500 Chacharonis, 1960 Rat oral > 30 ml approx. or eq. 20,400 Chacharonis, 1963 No treatment-related effects were detected during the observation of animals for 14 days after administration of single doses of 12 different caramels manufactured with ammonia or sulphate ammonia catalysts (Foote et al., 1958; Chacharonis, 1960; 1963). Single doses of caramel colour III of up to 10 g/kg b.w. in mice and 15 g/kg b.w. in rabbits did not cause convulsions or others signs of distress (Sharratt, 1971). Short-term studies Mice In a 4- to 6-week study, albino Swiss mice (10 males and 10 females/group) were fed caramel colour III containing 830 ppm 4-methylimidazole at concentrations of 0, 1, 2, 4, 8, or 16% in the diet. No influence of caramel colour III on appearance, behaviour, or food intake was observed. Growth was decreased, especially in the third and fourth weeks, in the groups fed 16% caramel colour III. The faeces of the animals fed the higher dose levels were soft, tarry in appearance, poorly-formed, and sticky or pasty in consistency. In the males fed 16% caramel colour III, an increase of neutrophilic leucocytes and a decrease in lymphocytes were observed. The mean relative weights of the caeca (full and empty) were increased at the 4, 8, and 16% dietary levels. No other remarkable findings were observed on gross examination; histopathological examinations were not conducted. No information is available on the THI content of the sample of caramel colour III used in this study, nor on the dietary levels of pyridoxine (Procter, 1976). In a pilot study to select the dose levels for a carcinogenicity study, B6C3F1 mice were fed caramel colour III for 13 weeks. No details of this study were reported (Hagiwara et al., 1983). Rats Four groups of 10 male and 10 female rats received either 0 or 10% of 2 different samples of caramel colour III in their diet for 90 days. Weight gains showed slight reductions compared with controls, but food consumption was normal in all groups. No abnormalities were noted regarding haematology, urinalysis, gross pathology, or histopathology. No information is available on the THI content of the samples of caramel colour III used in this study (Charcharonis, 1963). Four groups of rats received 0, 4, 8, or 16% caramel colour III in their diet for 3 months. No convulsions or other behavioural abnormality or signs of neurological damage were seen. No macroscopic pathological abnormalities were found in the central nervous system (Sharratt, 1971). Six groups of 15 rats (CFE strain) of each sex were fed diets containing 4, 8, or 16% caramel colour III produced by either an "open" or a "closed" pan process for 13 weeks; a group of 25 rats of each sex served as controls. Body-weight gain was decreased at all dietary levels of both caramel colours. Haemoglobin concentrations were reduced at the highest dietary levels at week 6, while at the lower levels this effect was less clear. After 13 weeks, the males at all dose levels had significantly decreased haemoglobin concentrations, but this effect occurred in females only at the 8 and 16% levels. In some groups there was a less consistent decrease in the total number of red blood cells at 6 and 13 weeks. The total number of leucocytes was significantly decreased and a lymphocytopenia was present at all dose levels at 6 and 10 weeks; at 13 weeks these changes were observed only in males. At necropsy, decreased weights of the thymus and spleen were observed at the 8 and 16% dose levels. The caecal weights were increased at the 8 and 16% dose levels compared with controls. Increased relative liver and kidney weights suggested an effect on these organs. Changes in the weights of other organs were considered to be related to the differences of body weight between the groups. The volumes of urine excreted during a 6-hour period without water or in the 2-hour period after a water load were lower than the control values. The latter differences were accompanied by higher values for the specific gravity of the urine. The histopathological study did not reveal treatment-related changes. No details of the THI content of the caramel colours used in this study were available (Gaunt et al., 1975). Seven groups of 20 female Wistar rats were fed diets containing 0, 15, or 30% of 3 types of caramel colour, one of which was a sample of caramel colour III, for 8 weeks followed by a 4-week recovery period. The diets containing caramel colour III caused dose-related decreases in body weights and food efficiency, and also caused diarrhoea at the 30% dietary level. Leucocyte counts at 4 weeks were significantly increased at the highest dose level whereas at 8, 10, and 12 weeks no differences were observed between test groups and controls. The relative weights of the caeca of animals receiving caramel colour III, both filled and empty, were increased at 4 and 8 weeks but reverted to normal after the 4-week recovery period. Gross examination at autopsy after 8 weeks revealed a slight, dose-related brown discolouration of the mesenteric lymph nodes in a few animals of each test group. After recovery periods of 2 or 4 weeks the discolouration was less intensive, but still visible. Microscopically, the lymph nodes of the test rats showed accumulation of pigment-laden macrophages, which was not noticeably diminished after withdrawal of the caramel for 2 or 4 weeks. No details of the THI content of the caramel colour III used in this study were available (Sinkeldam & van der Heyden, 1976a). In a 10-week feeding study, groups of 15 male and 15 female Sprague-Dawley rats were fed diets containing caramel colour III at concentrations of 0, 1.25, 2.5, 5.0, 10.0, or 15.0%. In the animals receiving caramel colour III at levels of 5% or higher, the faeces became soft within two weeks and the water content of the faeces was higher than the faeces of controls. Body-weight gains were generally reduced in animals fed caramel colour III, particularly during the last 2-4 weeks of the study. In rats fed caramel colour III, there were no changes in haemoglobin levels or erythrocyte counts; a significant reduction in lymphocyte counts and a coincident increase in the number of segmented neutrophils was observed at all dose levels. No macroscopic evidence of abnormal pigmentation of the mesenteric lymph nodes was found. An increase in empty caecal weight was consistently evident in animals of both sexes given caramel colour III at the 5, 10, and 15% levels. Histopathological examination did not reveal changes in the structure of the ileal or caecal mucosa nor in the reticuloendothelial components of the central or peripheral systems. No abnormal pigmentation of the lymph nodes was found. No details of the THI content of the caramel colour used in this study were available (Procter et al., 1976). Groups of 10 male and 10 female Wistar rats were fed diets containing caramel colour III at concentrations of 0, 1.25, 2.5, 5.0, 10.0, or 15.0% for 10 weeks. Caramel colour III caused loose stools, particularly at the 5% dietary level and body weights were slightly decreased in both sexes at this level. Leucocyte (lymphocyte) counts were decreased in males and in females fed 15% caramel colour III; at lower dose levels this effect occurred only in females. The relative weight of the caecum (both full and empty) was increased by feeding caramel colour III. Minimal amounts of pigment were observed in mesenteric lymph nodes of several rats fed 1.25% and higher levels of caramel colour III. From this experiment it appeared that caramel colour III was more active than two other types of caramel tested concurrently in regard to growth depression, enlargement of the caecum, and decrease in leucocyte counts. No details of the THI content were available (Sinkeldam & van der Heyden, 1976b). In a 10-week study, weanling Wistar rats were fed caramel colour III in the diet at levels of 0, 0.5, 1.0, 2.0, 4.0, or 16%. There were 15 males and 15 females in each group except for the control group, which had 60 animals of each sex, and the highest dose group, which had 10 animals of each sex. Food intake and growth rates were recorded, and haematological examinations and histopathological studies were carried out. In particular, the lymph nodes, thymus, spleen, and caecum were examined for distribution of pigment. Another 2 groups of 10 rats were given basal diet or diet containing 16% caramel colour III for 10 weeks followed by a 28-day period during which the basal diet was fed (recovery experiment). Five rats of each sex were killed after 7 days and the remainder after 28 days of the recovery period. Caramel colour III depressed body-weight gain at dietary levels greater than 1%. Total leucocyte counts were decreased in males in the groups receiving 2, 4, and 16% caramel colour III and in females receiving 4 and 16% caramel colour III. However, the lymphocyte/ neutrophil ratio was significantly decreased in both sexes at all dose levels. Relative liver weights were increased at dietary levels of 2% and higher levels of caramel colour III, and reduced spleen weights were observed at the highest (16%) dose level. Increased relative kidney weights were observed in both sexes at 2% and higher dietary levels of caramel colour III. Increased caecal weights were observed at the 16% dietary level; microscopically, pigment was observed in the mesenteric lymph nodes of male and female rats at this dose level. During the recovery phase, white cell counts, cell ratios, and total numbers of lymphocytes rapidly returned to normal; recovery was complete in both sexes by 7 days. The caecal weights had returned to normal by 7 days and the relative liver and spleen weights returned to normal during the recovery phase, while kidney weights partially recovered. No details of the THI content of the caramel nor of the pyridoxine content of diet were available (BIBRA, 1977). Test groups of 15 male and 15 female Sprague-Dawley rats were fed diets containing 10 or 15% caramel colour III for 4 weeks; a control group of 20 rats of each sex received basal diet. During the course of the study, the rats fed diets containing caramel colour III had soft dark-coloured faeces, particularly at the highest dietary level. There were no consistent differences in body-weight gain or food consumption and no mortality occurred. Haematological studies were conducted prior to feeding caramel colour III and after 2 and 4 weeks. In males, total white cell and lymphocyte counts were unaffected by treatment at either sampling interval or dose level. In females, total white cell and lymphocyte numbers were significantly depressed after 4 weeks but not at 2 weeks at both dose levels. However, significant differences in differential white cell counts were observed in both sexes. In males, the differential lymphocytes (%) were significantly depressed at both dose levels and treatment intervals, and there was a concomitant increase in segmented neutrophils. In females, the differential counts of lymphocytes and segmented neutrophils were similarly affected after 4 weeks. At necropsy, increased caecal weights were observed in both sexes and a statistically significant increase in relative weights of the thymus in male rats fed both doses of caramel colour III was noted. Histopathological studies were not conducted. Details of the THI content of the caramel sample used were not available (Procter, 1977). In a 13-week toxicity study, caramel colour III was administered in drinking water at concentrations of 0, 4, 6, 8, or 10% to groups of 10 male and 10 female weanling Wistar rats. The caramel colour III sample used was analysed and found to contain 78 mg/kg THI on an 'as is' basis, 105 mg/kg THI on a solids basis. The diet fed to the rats contained approximately 13 mg/kg pyridoxine. The general condition and behaviour of the animals was checked at frequent intervals, individual body weights were measured weekly, food consumption was measured (on a cage basis) over weekly periods during the whole experimental period, and fluid consumption was measured daily (on a cage basis). Samples of blood for haematology were collected from the tip of the tail of all rats initially and at days 29/30, 57/58, and 84/85. Urinalysis was performed on individual urine samples from all animals during the last 16 hours of a 24-hour period of deprivation of food and water at day 87. Tail tip blood collected at day 87 was examined for glucose and urea nitrogen. Blood was obtained from the aorta under ether anaesthesia at termination (day 91 for males, 92 for females), and the following assays performed on the plasma; alkaline phosphatase, GPT, GOT, lactate dehydrogenase, total protein, and albumin. Pyridoxal phosphate was measured in plasma from EDTA-treated blood samples. At autopsy the following organs were weighed: thyroid, adrenals, testes/ovaries, kidneys, thymus, brain, spleen, heart, liver, and caecum (full and empty). Histological examinations were carried out on all animals of the control and top-dose groups and, in addition to the weighed organs, the following organs/tissues were examined: aorta, axillary and mesenteric lymph nodes, cervix, colon, oesophagus, stomach, duodenum, ilium, jejunum, lungs, epididymides, pituitary, prostate, skeletal muscle, skin, sternum, pancreas, trachea, urinary bladder, uterus, and all gross lesions. There was a dose-related decrease in fluid consumption, decreased urinary output of more concentrated urine, decreased food consumption, and decreased body-weight gain in both sexes. These changes were related to the palatability of the drinking fluid. No outstanding differences were observed in red blood cell analyses between test groups and controls. Total lymphocyte counts were relatively low in all test groups of both sexes. The differences from control values were statistically significant in all male treatment groups after 29/30 days, in the female 8% group after 29/30 days, and in the male 4 and 8% groups after 57/58 days. However, these differences did not show a clear dose-dependent relationship and at 13 weeks there were no significant differences among any of the treatment groups compared to controls. At necropsy, the relative weights of the kidneys and caecum were increased in several groups receiving caramel colour III. The increase in kidney weight was dose-dependent, but no treatment-related histopathological changes were seen in any of the organs examined and the enlargement of the kidneys was attributed to the decreased fluid consumption by the treated rats. No effects on the relative weights of spleen or thymus were observed and these tissues were histologically normal (Sinkeldam et al., 1980b). A 13-week toxicity study was conducted with caramel colour III given in the drinking water at concentrations of 0, 5, 10, 15, or 20% to groups of 10 male and 10 female weanling Wistar rats. The caramel colour III sample used in this study contained 0-3 mg/kg THI on an 'as is' basis. The diet fed to the rats contained 13.5 mg/kg pyridoxine. The protocol used was similar to that described in the previous study except that blood samples were collected at days 30/31, 57/58, and 80/81, and urinalysis was performed at day 85. Water intake (fluid intake corrected for caramel colour solids content) showed a dose-related decrease in both sexes. Food intake was also generally lower in all treated groups. Body-weight gains of males were decreased in a dose-related manner, while body-weight gains of females were comparable to controls. Urine volumes were decreased in rats treated with caramel colour III and the urines were more concentrated in treated groups than in controls. These changes were attributed to the decreased water intake. The urine was darker- coloured at the 15 and 20% dose levels; however, urine composition was essentially normal. Lymphocyte counts were in general relatively low in all test groups in both sexes but the differences only attained statistical significance in males of the top-dose group after 30 days and males of all treatment groups after 57 days. No significant differences in lymphocyte counts were observed in males of any group after 80 days, nor in females at any dose level at any time interval. Mean neutrophil counts were significantly increased in females receiving 20% caramel colour III for 81 days. Although the relative weights of the caecum, liver, brain, kidneys, and testes were increased in several test groups, there were no pathological changes in any of these organs. Treatment-related microscopic changes consisting of increased numbers of macrophages containing a yellow-brown PAS-positive pigment were found in the mesenteric lymph nodes. These were the only treatment-related changes noted (Sinkeldam et al., 1980a). Groups of 10 male and 10 female weanling F344 rats were given caramel colour III in the drinking water at concentrations of 0, 0.5, 1.0, 2.0, 4.0, or 8.0% for 4 weeks. The sample of caramel colour III used was found to contain 70 mg/kg THI on an 'as is' basis and the NIH 07 Open Formula Mouse and Rat diet used in this study contained 17 mg/kg pyridoxine. No differences in body-weight gain were noted for any of the test groups, although food consumption of the males was significantly lower than controls throughout the study. Transient decreases in lymphocyte counts were noted among the treatment groups at the midpoint of the study, but no significant differences between control and treated groups were noted at 1 month. Other haematological and clinical chemistry parameters were normal for all groups. At necropsy no differences in organ weights were noted between treated and control groups and there were no gross or microscopic pathological changes related to treatment (Heidt and Rao, 1981). Groups of 10 male and 10 female F344 rats were given caramel colour III in the drinking water at concentrations of 0, 1.25, 2.5, 5.0, 10.0, or 20.0% for 13 weeks in order to select doses for long- term carcinogenicity/chronic toxicity studies. Rats were given 20 ml/day of these solutions and basal diet (CRF-1, Charles River Japan, Inc.) was available ad libitum. The caramel colour III used contained 78 mg/kg THI on an 'as is' basis and the diet contained 11-12 mg/kg pyridoxine. During the experimental period, all animals were observed daily and clinical signs were recorded. Body weights were measured every other week and haematological examinations were performed every 4 weeks in the control and 20% groups. At the end of the study, all survivors were sacrificed for gross and microscopic examination. Weight gains were less in all experimental groups than in the control group from the first experimental week, and in week 13 the weight gains of the 1.25, 2.5, 5.0, 10.0, and 20.0% groups were 89, 94, 84, 76, and 76%, respectively, of that of controls for males and 96, 98, 80, 84, and 92%, respectively, for females. Except in the male 2.5% group and the female 1.25, 2.5, and 20.0% groups, the differences in weight gain from the controls were significant. No haematological changes were observed either during or at the end of the experimental period. At necropsy, no pronounced macroscopic changes were observed in any animals, although a few rats in the experimental groups were very emaciated. No histological changes related to caramel colour III administration were found in any experimental groups. From these results, the authors concluded that 1 and 4% caramel colour III in drinking water were the appropriate dose levels for a carcinogenicity study (Maekawa et al., 1983). In a 90-day toxicity study, 2 samples of caramel colour III were used, one containing approximately 15 mg/kg THI on a solids basis (batch A) and the other containing 295 mg/kg THI on a solids basis (batch B). Groups of 20 male and 20 female weanling F344 rats were given caramel colour III in drinking water at dose levels of 0, 10, 15, or 20 g/kg b.w. of batch A and 20 g/kg b.w. of batch B. The NIH 07 Open Formula Mouse and Rat diet used in this study contained more than 10 mg/kg pyridoxine. During the study, body weights and food intake were recorded weekly. Fluid consumption was recorded 3 times per week and concentrations of the test material were adjusted on the basis of body weight and fluid intake to give the required dose. Haematological analyses were performed at 2 and 6 weeks and at termination, and clinical chemistry analyses were carried out at 6 weeks and termination. At necropsy, all animals were examined macroscopically and selected organ weights were determined. Histopathological examinations were conducted on the 20 g/kg test groups and on the control animals. Although the findings were not always consistent, the animals treated at the higher dose levels (15 and 20 g/kg) of batch A and those teated with batch B generally had decreased body weights. All treated groups had significantly decreased food and fluid intake. If fluid intake values are corrected for solid contents of the caramel colours, the values for water intake were markedly below those of the controls. Because of the rather constant fluid intake of the treated groups, it was necessary to increase progressively the caramel colour concentration to maintain a constant intake of the caramel colour on a body-weight basis. It is likely that the effects on body-weight gain and food consumption were due to the reduced water intake of the rats, reflecting the poor palatability of the drinking solution rather than toxic effects of the caramel colour per se. The haematology studies revealed decreased lymphocyte counts in the male and female rats fed batch B at 2 weeks and in the male rats fed batch B at 6 weeks. All lymphocyte values in these groups were normal at the termination of the study. No decreases in lymphocyte counts occurred in male or female groups fed batch A at any of the dose levels. There were no consistent changes in clinical chemistry values, with the exception of slightly increased values in blood urea nitrogen in the rats treated with batch B. Urinalysis revealed decreased urinary volume and increased specific gravity in rats of both sexes treated with either batch of caramel colour III at 6 weeks. At termination, these differences were only significant in male rats in the top-dose groups (both batches). Treatment-related increases were observed in the absolute and relative weights of the caecum (full and empty) in animals of both sexes at all dose levels. Dose-related increases occurred in absolute and relative kidney weights and were considered to reflect compensatory hypertrophy as a consequence of reduced water intake; there were no histopathological changes in the kidneys of any of the test groups. A dose-related decrease in the absolute weight of the thymus was observed, which reached statistical significance in the top-dose group males with both samples of caramel colour III and top-dose group females with batch B; this decrease was not evident when the thymus weight was expressed relative to body weight. Other differences in absolute and relative organ weights appeared to be a consequence of the dose-related reduction in body weight. The only treatment-related microscopic changes noted were minimal to moderate accumulation of pigment in the tissues of the intestinal tract and mesenteric lymph nodes without pathologic alteration. Although statistically-significant changes were identified in some clinical and anatomical parameters, the authors did not consider them to be toxicologically important. On this basis, the no-adverse- effect level for ammonia caramel III was considered to be 20 g/kg b.w. (MacKenzie, 1985). A paired-feeding study was conducted to determine whether poor palatability is the mechanism underlying the decreased body-weight gains frequently noted in toxicity studies of caramel colour III. A group of 10 male Wistar rats were fed 12% caramel colour III in the drinking water, and similar groups were permitted a limited intake of food or water equivalent to that consumed by the caramel colour III group. Body-weight gain and food and fluid intake were decreased in the group fed caramel colour III. A similar decrease in body-weight gain was noted in the groups of rats restricted to the equivalent intake of either food or water. The author concluded that the growth depression observed in rats when caramel colour III is fed in the drinking water is the result of decreased fluid and food intake. Poor palatability of drinking fluid containing caramel colour III was the probable cause of these changes (Sinkeldam, 1979). Long-term studies Rats Four groups of 48 male and 48 female Wistar rats were given diets containing 0, 1, 3, or 6% caramel colour III (ammonia catalysed "half open-half closed pan" caramel; no indication about the presence of 4-methylimidazole was given) for 2 years. Food and water intake, growth, mortality, and organ weights were measured; haematological examinations, urinalyses, kidney function tests, and histopathological examinations also were carried out. A decrease in growth, which was significant in the males, was observed at all dose levels. This effect was accompanied by a reduction in the cumulative food intake. A significant reduction in white cell number (in the 6% group) was associated in the early part of the study with a lymphocytopenia, which was present until week 80 in the male rats fed a diet containing 3 or 6% caramel. In the female animals the lymphocytopenia was present until week 52 in these 2 groups (the 1% group was not tested). Spleen weights were reduced in a dose-related manner. The relative weights of the (full) caeca were clearly increased at all dose levels. No changes were found in the pancreata of the control animals, while in the test groups (not dose-related) a total of 10 hyperplastic changes were found. However, the number of tumours of the pancreas showed no relation to the administration of caramel. There was no evidence of a carcinogenic effect. The authors concluded that a no-observed-effect level could not be established for the caramel used in this particular study (Evans et al., 1976). Observations in man In a number of animal studies with caramel colour III, a decrease in the total number of leucocytes associated with a decrease in the number of lymphocytes was noted. A pilot study in humans was carried out in which 1.5 g of caramel colour III (prepared by a closed-pan process) was ingested daily by 9 volunteers for 21 days. Total circulating leucocytes, lymphocytes, and erythrocytes, together with haemoglobin concentrations, were measured prior to and during the treatment. No changes were found that could be attributed to treatment with caramel colour III. In this experiment 6 of the subjects showed no differences from normal in stool frequency or condition. Three volunteers occasionally had soft stools; no control groups were used (BIBRA, 1976). Comments The temporary ADI for caramel colour III was revoked at the twenty-first meeting of the Committee due to its effects on circulating total leucocytes and lymphocytes. Since that time, a component of caramel colour III, 2-acetyl-4(5)- tetrahydroxybutylimidazole (THI), has been identified and shown to cause a depression of lymphocyte counts; the lymphocyte depression caused by caramel colour III has been shown to be due largely, if not solely, to this minor component. Comparison of the lymphocyte- depressing activity of pure THI with a batch of caramel colour III containing a known level of THI indicated that other components of this batch had an insignificant activity. The lymphocyte depression was largely ameliorated by dietary pyridoxine. In studies on samples of caramel containing 10 mg/kg THI, no effects on lymphocyte counts were observed with adequate dietary levels of pyridoxine. Long-term studies in rats and mice indicate that caramel colour III is not carcinogenic at dose levels of up to 4% in drinking water, which was also the no-effect level in these long-term studies. EVALUATION Level causing no toxicological effect As it was not possible to include caramel colour III at higher levels than 4% in drinking water in long-term studies, and as the effect of most concern, i.e. lymphopenia, could best be evaluated from short-term studies, the Committee based its evaluation on the no-effect level of 20 g/kg b.w./day in a 90-day study in rats using caramel colour III which contained approximately 15 ppm THI on a solids basis (10 ppm on an 'as is' basis). Estimate of acceptable daily intake for man 0-200 mg/kg b.w. (0-150 mg/kg b.w. on a solids basis). Further work or information Desired Analytical data to confirm that the sample on which the evaluation is based is representative of current commercial samples. Studies to confirm that THI is the sole component of caramel colour III that has lymphocyte-depressing activity and to establish a no-effect level for THI. REFERENCES Allen, J.A., Brooker, P.C., Birt, D.M., & McCaffrey, K.J. (1984). Analysis of metaphase chromosomes obtained from CHO cells cultured in vitro and treated with caramel colour III. Unpublished report No. ITC 3B/84966 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Allen, J.A. & Proudlock, R.J. (1984). Autoradiographic assessment of DNA repair in mammalian cells after exposure to caramel colour III. Unpublished report from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Ashoor, S.H. & Monte, W.C. (1983). Mutagenicity of commercial caramels. Cancer Letters 18, 187-190. BIBRA (1976). A study of the haematological effects of caramel in human volunteers. Unpublished report No. 1/172/76 from the British Industrial Biological Research Association, Carshalton, Surrey, England. Chacharonis, P. (1960). Acute and chronic toxicity studies on caramel colours A and B. Unpublished report No. S.A. 54219 from Scientific Associates Inc., St. Louis, MO, USA. Chacharonis, P. (1963). Acute oral toxicity study in rats on caramel colorings 25A-1, 30B-0, and 30F-1. Unpublished report No. S.A. 79105 from Scientific Associates Inc., St. Louis, MO, USA. Cimino, M.C. & Brusick, D.J. (1981). Mutagenicity evaluation of ETA 48-IH caramel color in the mouse micronucleus test. Unpublished report No. 22129 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Evans, J.G., Butterworth, K.R., Gaunt, I.F., & Grasso, P. (1976). Long-term toxicity study in the rat of a caramel produced by the "half-open-half closed pan" ammonia process. Unpublished report No. 6/1976 from the British Industrial Biological Research Association, Carshalton, Surrey, England. Foote, W.L., Robinson, R.F., & Davidson, R.S. (1958). Toxicity of caramel color products. Unpublished report of Battelle Memorial Institute, Columbus, OH, USA. Galloway, S.M. & Brusick, D.J. (1981a). Mutagenicity evaluation of ETA-48-IH in an in vitro cytogenetic assay measuring chromosome aberration frequencies in Chinese hamster ovary (CHO) cells. Unpublished report No. 20990 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Galloway, S.M. & Brusick, D.J. (1981b). Mutagenicity evaluation of ETA-48-IH in an in vitro cytogenetic assay measuring chromosome aberration frequencies in Chinese hamster ovary (CHO) cells. Part II. Unpublished report No. 20990 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Gaunt, I.F., Lloyd, A.G., Grasso, P., Gangolli, S.P., & Butterworth, K.R. (1975). Toxicological investigations of caramels. I. A short-term study in the rat with two caramels produced by variations of the ammonia process. Unpublished report No. 14 from the British Industrial Biological Research Association, Carshalton, Surrey, England. Hagiwara, A., Shibata, M., Kurata, Y., Seki, K., Furushima, S., & Ito, N. (1983). Long-term toxicity and carcinogenicity test of ammonia-process caramel colouring given to B6C3F1 mice in the drinking water. Fd. Chem. Toxicol. 21, 701-706. Haldi, J., & Wynn, W. (1951). A study to determine whether or not caramel has any harmful physiological effect. I. Unpublished report from Emory University, Atlanta, GA, USA. Heidt, M. & Rao, G.N. (1981). Subchronic toxicity study of ammonia caramel color type AC2 in rats. Unpublished report No. 80036 from Raltech Scientific Services, Inc., Madison, WI, USA. Submitted to WHO by International Technical Caramel Association. Ishidate, M. Jr. & Yoshikawa, K. (1980). Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation - a comparative study on mutagens and carcinogens. Arch. Toxicol. Suppl. 4, 41-44. Jagannath, D.R. & Brusick, D. (1978a). Mutagenicity evaluation of ETA 4-10, ETA 4-11, ETA 4-15 in the Ames Salmonella/microsome plate test. Unpublished report No. 20838 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Jagannath, D.R. & Brusick, D. (1978b). Mutagenicity evaluation of ETA 4-8, ETA 4-9, ETA 4-12, ETA 4-13, ETA 4-14 in the Ames Salmonella/microsome plate test. Unpublished report No. 20838 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Jensen, N.J., Willumsen, D., & Knudsen, I. (1983). Mutagenic activity at different stages of an industrial ammonia caramel process detected in Salmonella typhimurium TA 100 following pre- incubation. Fd. Chem. Toxicol. 21, 527-530. Kawachi, T., Yahagi, T., Kada, T., Tazima, Y., Ishidate, M., Sasaki, M., & Sugiyama, T. (1980). Cooperative programme on short-term assays for carcinogenicity in Japan. In Molecular and Cellular Aspects of Carcinogen Screening Tests, IARC Scientific Publication No. 27, 323-330. International Agency for Research on Cancer, Lyon, France. Kawana, K., Akema, R., Nakaoka, T., Ikeda, H., Takimoto, T., & Kawauchi, S. (1980). Studies on mutagenicities of natural food additives. II. Mutagenicities and antibacterial activities of caramels. Eisei Kagaku 26, 259-263. Kroplien, U. (1984). Letter dated 17 December 1984 to International Technical Caramel Association, submitted to WHO. Kroplien, U., Rosdorfer, J., van der Greef, J., Long, R.C. Jr., & Goldstein, J.H. (1985). 2-Acetyl-4(5)-(tetrahydroxybutyl)- imidazole: Detection in commercial caramel colour III and preparation by a model browning reaction. J. Org. Chem. 50, 1131-1133. MacKenzie, K.M. (1985). 90-day toxicity study of caramel color (ammonia process) in rats. Vols. I & II. Unpublished report No. 6154-107 from Hazleton Laboratories America, Inc., Madison, WI, USA. Submitted to WHO by International Technical Caramel Association. Maekawa, A., Ogiu, T., Matsuoka, C., Onodera, H., Furuta, K., Tanigawa, H., Hayashi, Y., & Odashima, S. (1983). Carcinogenicity study of ammonia-process caramel in F344 rats. Fd. Chem. Toxicol. 21, 237-244. Morgareidge, K. (1974). Teratologic evaluation of FDA 71-82 (caramel, bakers and confectioners) in mice, rats and rabbits. Unpublished report No. PB 234-870 from Food and Drug Research Laboratories Inc., Waverly, NY; USA. Nishie, K., Waiss, A.C., & Keyl, A.C. (1969). Toxicity of methylimidazoles. Toxicol. Appl. Pharmacol. 14, 301-307. Nishie, K., Waiss, A.C., & Keyl, A.C. (1970). Pharmacology of alkyl and hydroxyalklpyrazines. Toxicol. Appl. Pharmacol. 17, 1. Procter, B.G. (1976). A preliminary evaluation of the potential toxicological effects of ammonia caramel in mice. Unpublished report No. 5705 from Bio-Research Laboratories Ltd., Pointe Claire, Quebec, Canada. Procter, B.G. (1977). A preliminary evaluation of the potential toxicological effects of ammonia caramel (U.S. origin) in rats. Unpublished report No. 5617 from Bio-Research Laboratories Ltd., Pointe Claire, Quebec, Canada. Submitted to WHO by International Technical Caramel Association. Procter, B., Berry, G., & Chappel, C.I. (1976). A toxicological evaluation of various caramels fed to albino rats. Unpublished report No. 4244 from Bio-Research Laboratories Ltd., Pointe Claire, Quebec, Canada. Richold, M. & Jones, E. (1980). Ames metabolic activation test to assess the potential mutagenic effect of ETA-48-1H. Unpublished report No. FDC 8/80358 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Richold, M., Jones, E., & Fenner, L.A. (1984). Ames metabolic activation test to assess the potential mutagenic effect of caramel colour III. Unpublished report No. ITC 1B/84709 from Huntingdon Research Centre, Huntingdon, England. Submitted to WHO by International Technical Caramel Association. Sharratt, M. (1971). Unpublished report. Sinkeldam, E.J. (1979). Paired feeding test in rats with caramel (AC3) in drinking water. Unpublished report No. R 6157 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J. (1981). Quantitative relationship between dietary pyridoxine content and lymphocyte counts in rats fed ammonia caramel. Unpublished report No. V81.390/211704 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J. (1982a). Quantitive relationship between dietary pyridoxine content and lymphocyte counts in mature rats fed ammonia caramel. Unpublished report No. V82.102/220102 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J. (1982b). Short-term (7 day) bioassay in rats with three dose levels of 2-acetyl-4(5)-tetrahydroxybutylimidazole (13-A-82). Unpublished report No. V82.291/221153 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J., Bruyntjes, J.P., & Kuper, C.F. (1980a). Sub-chronic (13-week) oral toxicity study with a modified ammonia caramel (ETA-26-1) in rats. Unpublished report No. R 6483 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J., Roverts, W.G., & Kuper, C.F. (1980b). Sub-chronic (13-week) oral toxicity study with ammonia caramel (AC2) in rats. Unpublished report No. R 6121 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J., de Groot, A.P., van den Berg, H., & Chappel, C.I. (1984). The effect of vitamin B6 on the number of lymphocytes in blood of rats fed caramel colour (ammonia process). Unpublished report submitted to WHO by International Technical Caramel Association. Sinkeldam, E.J. & van der Heyden, C.A. (1976a). Short-term feeding test with three types of caramels in albino rats. Unpublished report No. R 4789 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Sinkeldam, E.J. & van der Heyden, C.A. (1976b). Short-term (10 week) feeding study in rats with three different ammonia caramels. Unpublished report No. R 5120 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. CARAMEL COLOUR IV EXPLANATION The report of the twenty-fourth meeting of the Committee (Annex 1, reference 53) drew attention to the need for adequate specifications for caramel colour IV and for a long-term study of carcinogenicity. The temporary ADI of 0-100 mg/kg b.w. was extended pending the results of long-term toxicity studies. BIOLOGICAL DATA Biochemical Aspects Absorption, distribution, and excretion Pigmentation of tissues of the lymphoreticular system, particularly of the mesenteric lymph nodes, has been a frequent observation in rats fed high levels of caramel colour. A study was undertaken to determine the distribution of the colour component of caramel colour in rats and to determine whether accumulation of caramel colour was the cause of pigmentation in the mesenteric lymph nodes. Experimental batches of unlabelled and 14C-labelled caramel colour IV were prepared and a concentrate of the higher molecular- weight colour components was made by ultrafiltration. The absorption, tissue distribution, and excretion of this fraction was studied in male F344 rats after a single oral gavage of 2.5 g/kg b.w. 14C-Labelled material was administered to naive animals and to animals which had received 2.5 g/kg b.w. unlabelled material in drinking water daily for 13 days prior to administration of 14C-labelled material. Differences between the results in naive and pretreated animals were small. Most of the colour components were not absorbed, but instead were excreted in the faeces, mainly within 48 hours. By 96 hours after dosing, 99.7-102.4% of the administered dose was excreted in the faeces, with only 1-2% in urine and insignificant amounts (< 0.1%) as 14CO2 in expired air. Groups of 4 rats were killed at intervals of 4, 8, 12, 24, and 96 hours after receiving the single oral dose of 14C-labelled material, and radioactivity was measured in the following tissues/organs; blood, brain, heart, lungs, liver, kidneys, spleen, thymus, mesenteric and cervical lymph nodes, gastrointestinal tract (contents and tissues), and carcass. Most of the radioactivity was located in the gastrointestinal tract, and only low levels of radioactivity were found in blood and tissues. The specific activity in the thymus, mesenteric lymph nodes, spleen, kidneys, and liver exceeded that in blood, but with the exception of the mesenteric lymph nodes, the radioactivity was cleared rapidly over the 96-hour study period. With the exception of the gastrointestinal tract, the highest tissue levels attained, in the liver and kidneys, never exceeded 0.02% and 0.01% of the administered dose. The results demonstrate that, after administration of large doses of the coloured components of caramel colour IV, only a small fraction was absorbed, distributed in lymphoreticular tissue, and eventually excreted in the urine; retention by the mesenteric lymph nodes appeared to account for the pigmentation observed in this tissue (Selim, 1982). Toxicological studies Special studies on carcinogenicity (See also long-term studies) Mice A carcinogenicity study of caramel colour IV was performed on B6C3F1 mice using 5 groups of 50 male and 50 female mice in each group. Two groups of each sex served as controls and the 3 treatment groups received caramel colour IV in the drinking water at dose levels of 2.5, 5.0, or 10.0 g/kg b.w./day for 104 weeks. All animals were observed twice daily and palpated for tissue masses weekly from week 27. Body weights and food intake were recorded weekly, and fluid intake was measured on the first, third, fifth, and seventh days of the first 12 weeks and over a 48-hour period each week thereafter. A complete necropsy was performed on all animals dying on test or sacrificed in a moribund condition, and on all survivors at termination. Histology (haematoxylin and eosin staining) was performed on all gross lesions and on the following organs/tissues of all animals: adrenals, brain (three sections), bone, bone marrow, epididymis, oesophagus, eyes, gall bladder, heart, intestine (duodenum, ileum, caecum and colon), kidneys, liver, lymph nodes (cervical, mesenteric, and thoracic), mammary glands, ovaries, pancreas, parathyroid, pituitary, prostate, salivary gland, sciatic nerve, seminal vesicle, skin, spinal cord, spleen, stomach, testes, thymus, thyroids, trachea, urinary bladder, and uterus. Four animals were found in the wrong cages during week 15 and had probably been misplaced 9 weeks earlier. These animals were removed from the study during week 31 and were not included in subsequent examinations. Although during the course of this study there were sporadic significant differences in mean body weights of treated male and female groups compared to controls, caramel-colour feeding did not have consistent effects on body weights or body-weight gains in either sex. Males of the 10 g/kg b.w.-dose group had lower mean food consumption than the control groups for 67 of the 104 weeks and males receiving 2.5 g/kg b.w. had lower mean food consumption for 21 of the 104 weeks. There were no consistent differences in food intake of males at the 5 g/kg b.w. dose level nor of any of the females. Decreased fluid intake was noted, particularly in males at the higher dose levels; mean fluid intakes of treated females were usually equal to or only slightly lower than controls. There were no treatment- related differences in survival rates, which at termination were 65-75% for the male groups and 67-79% for the female groups. At necropsy, there were dose- and/or treatment-related effects on the gastrointestinal tract and mesenteric lymph nodes, including dark gastrointestinal contents, staining of the mucosa, and diffusely red and congested mesenteric lymph nodes. These changes were not considered to be toxicologically important and there were no other changes of toxicological significance. There was no evidence of treatment-related neoplastic lesions in any organs (MacKenzie, 1985b). Rats A long-term toxicity and carcinogenicity study of caramel colour IV was conducted on F344 rats. In the carcinogenicity portion of the study, 5 groups of 50 male and 50 female weanling rats were selected randomly; 2 groups of each sex served as controls and the 3 treatment groups received caramel colour IV in drinking water at dose levels of 2.5, 5.0, or 10 g/kg b.w./day for 24 months. In the chronic toxicity portion of the study, groups of 25 male and 25 female rats received caramel colour IV in drinking water at doses of 0, 2.5, 5.0, 7.5, or 10 g/kg b.w./day for 1 year. The following parameters were monitored: mortality, clinical observations including ophthalmic changes, body weight, and food and fluid consumption. In the chronic toxicity portion clinical chemistry and haematological studies were done at intervals of 6 and 12 months and necropsies were performed at 12 months. In the carcinogenicity portion of the study, a complete necropsy was performed on all animals dying on test or sacrificed in moribund condition, and on all survivors at termination. Histology (haematoxylin and eosin staining) was performed on all gross lesions and on the following organs/tissues of all animals: adrenals, brain (three sections), bone, bone marrow, epididymis, oesophagus, eyes, heart, intestine (duodenum, ileum, caecum, and colon), kidneys, liver, lung, lymph nodes (cervical, mesenteric, and thoracic), mammary gland, ovaries, pancreas, parathyroid, pituitary, prostate, salivary gland, sciatic nerve, seminal vesicle, skin, spinal cord, spleen, stomach, testes, thymus, thyroid, trachea, urinary bladder, and uterus. The feeding of caramel colour IV did not affect survival in either the chronic toxicity or carcinogenicity sections of this study and, other than dark-stained and soft faeces, there were no treatment- related antemortem observations. During the course of both studies body weights were reduced for both males and females at the 5 and 10 g/kg b.w. dose levels. These effects on body weights were correlated with reduced water and food consumption at these dose levels and reflect the reduced palatability of the drinking fluid. Clinical chemistry and haematological studies at 6 and 12 months in the chronic toxicity study did not reveal changes of toxicological concern. At 6 months, serum concentrations of blood urea nitrogen and creatinine were reduced in male groups treated with 5.0, 7.5, and 10 g/kg b.w. and in female groups treated with 7.5 and 10 g/kg b.w. caramel colour. Similar changes were noted at 12 months. Creatinine levels were within the normal range for the F344 rat, whereas blood urea nitrogen levels were slightly outside this range. Decreased levels of serum total protein, albumin, and globulin were also noted at the 6-month sampling, particularly in male rats. These changes, which were less marked at 12 months, were not accompanied by any pathology in the liver or kidneys and were not considered to be of toxicological importance. The urinalysis studies revealed generally reduced urine volume and increased specific gravity in both sexes. At necropsy the changes noted were characteristic of the feeding of high levels of caramel colour, which consisted primarily of brown staining of the gastrointestinal tract and mesenteric lymph nodes and caecal enlargement. Increased kidney weights were noted in both sexes in animals fed caramel colour IV; no histologic alterations were present that could be associated with the increased renal weight, which the authors considered to be related to the water imbalance in these animals. Microscopic examination of the tissues of these animals did not reveal specific toxicological changes. Pigmentation in the gastrointestinal tract and mesenteric lymph nodes was observed. There was no evidence of reactive hyperplasia to the pigment in the mesenteric lymph nodes of the gastrointestinal tract. In the chronic portion of the toxicity study, although statistically significant changes were noted in some parameters, they were not considered to be toxicologically important. The highest dose fed, 10 g/kg b.w., was considered to be the no-adverse-effect level. In the carcinogenicity portion of the study, the observations were generally similar to those in the chronic portion. Survival at 24 months ranged from 64-68% for males and 82-92% for females. Random variations in both benign and malignant neoplasms typical of the F344 strain and this age of animal were observed; however, there were no treatment-related differences. The authors concluded that the feeding of caramel colour IV at doses up to 10 g/kg b.w. for 24 months did not induce neoplastic changes or non-neoplastic changes of toxicological importance (MacKenzie, 1985a). Special studies on mutagenicity Caramel colour IV was evaluated for genetic activity in a series of in vitro microbial assays with and without metabolic activation. Salmonella typhimurium (strains TA1535, TA1537, and TA1538) and Saccharomyces cerevisiae were used. Caramel colour IV was not genetically active under the test conditions employed in this study (Brusick, 1974). Caramel colour IV was evaluated for mutagenicity using the Ames Salmonella/microsome plate test and the Saccharomyces/microsome plate test. The samples tested were blends of 3 samples of caramel colour IV (low colour intensity) and 3 samples of caramel colour IV (high colour intensity). The Salmonella test organisms used were TA98, TA100, TA1535, TA1537, and TA1538. Tests were conducted directly or in the presence of liver microsomal enzyme preparations from Araclor-induced rats. Tests were conducted over a range of concentrations from 1-50 mg/plate. No signs of genetic activity were observed with any of the samples of caramel colour IV tested using either the Salmonella or Saccharomyces test organisms (Jagannath & Brusick, 1978a). The clastogenicity of caramel colour IV (low colour intensity) was evaluated in an in vitro cytogenetic assay using cultured Chinese hamster ovary cells without metabolic activation. No increase in chromosome aberrations was observed at concentrations of test material between 5 µg/ml and 5 mg/ml. In the same test, sodium ascorbate produced a positive response at 2 mg/ml (Galloway & Brusick, 1981a). The clastogenicity of caramel colour IV (high colour intensity) was evaluated in an in vitro cytogenetic assay using Chinese hamster ovary cells without metabolic activation. No increase in chromosome aberrations was observed at concentrations of test material between 5 µg/ml and 5 mg/ml. In the same test, sodium ascorbate produced a positive response at 2 mg/ml (Galloway & Brusick, 1981b). Two samples of caramel colour IV of medium and high colour intensity were assayed for mutagenic activity in the Ames test using Salmonella strains TA98 and TA100 in the absence or presence of rat hepatic S-9 fraction. Neither sample showed mutagenic activity under the conditions of the test (Ashoor & Monte, 1983). Thirteen commercial caramel colours (not identified) were examined for mutagenicity in the Ames test using Salmonella strains TA98 and TA100, with and without metabolic activation, and for DNA-damage effects on E. coli (Wild/pol A-; Wild/rec A-). None of the caramel-colour samples tested showed mutagenic activity in these tests (Kawana et al., 1980). Five samples of commercial caramel colour were tested for mutagenic activity against Salmonella strains TA98 and TA100 in the Ames test. All samples were reported to show equivocal results with strain TA100, and 2 were equivocal with TA98 (Kawachi et al., 1980). Five samples of caramel colour were tested in a chromosome aberration test in a cultured cell line of Chinese hamster lung fibroblasts, in the presence or absence of hepatic S-9 fraction. Ames tests were also conducted using Salmonella strains TA98, TA100, and TA1537, with or without metabolic activation and with a 20-minute pre-incubation step. All samples of caramel colour were designated as positive in the Ames assay and in the chromosome aberration test (aberrations were detected in 20% of metaphase cells) (Ishidate & Yoshikawa, 1980). The same series of 5 caramel-colour samples as used in the above studies were tested for mutagenicity in the Ames test using Salmonella strains TA98, TA100, TA1535, TA1537, and TA1538 and Saccharomyces strain D4. Assays were performed both in the presence and absence of hepatic microsomal S-9 fraction from Araclor-induced rats in the conventional plate assay and after a pre-incubation step in strains TA100 and TA1535. The results of the mutagenicity assays were negative under all the test conditions and over a concentration range of 1-50 mg/plate for strain TA100 and 1-20 mg/plate for the other strains (Jagannath & Brusick, 1978b). Special studies on reproduction Fifteen male and female Wistar rats were given 0 or 10% caramel colour IV solution as their sole fluid source until day 100 and were then mated. Animals of the F1-generation (25 males and 25 females) were weaned and again given 0 or 10% caramel solution until day 100. There were no adverse effects with regard to the number of litters born and the number of pups/litter. No influence on haematology, growth, food consumption, gross pathology, or histopathology of the F1-generation at 100 days of age was observed (Haldi & Wynn, 1951). Six different samples of caramel colour IV (3 single-strength (SS) and 3 double-strength (DS) products), each containing a different level of 4-methylimidazole (between 200 and 850 ppm) were tested in a reproduction study in rats. Two control diets were used, an unmodified stock diet and the stock diet supplemented with starch and cellulose. The various test diets are shown in the following diagramme. Composition of the test diet (in g) Group 1 2 3 4 5 6 7 8 9 10 11 12 Caramel in % 5 10 15 10 10 2 4 6 4 4 0 0 stock diet 100 100 100 100 100 100 100 100 100 100 100 100 wheat starch 3.8 1.9 - 1.9 1.9 4.9 4.1 3.4 4.1 4.1 5.8 - cellulose 4.2 2.2 - 2.2 2.2 5.4 4.6 3.8 4.6 4.6 6.2 - SSa caramel colour IV + 202b 5.6 11.5 17.6 SS caramel colour IV + 400 11.5 SS caramel colour IV + 600 11.5 DSc caramel colour IV + 350 2.3 4.5 6.8 DS caramel colour IV + 639 4.5 DS caramel colour IV + 852 4.5 a SS=Single stength b Quantity of 4-methylimidazole in ppm c DS=Double strength Twelve groups of 10 male and 20 female weanling Wistar rats were allocated to the above dietary groups and, at week 12, the rats were mated in sub-groups of 5 males and 10 females. After a 3-week mating period, the females were caged individually. At weaning age of the F1 generation, 40 males and 40 females were selected from as many different litters as possible within each caramel-colour group and continued on the same diet as the parent generation. Ten males and 10 females of each group were sacrificed after one year (see Sinkeldam et al., 1975, under short-term toxicity studies); the remaining 30 males and 30 females of each group were fed the test diets for 2 years (see Sinkeldam et al., 1976, under long-term toxicity studies). After weaning the F1 litters, the dams were killed and the implantation sites were counted. No consistent, dose-related effects on growth of the F0 animals were noted. No adverse effects were seen on female fertility, litter size, average weight and growth of the pups, or number of implantation sites or sex ratio of the young. In one group (10% SS caramel colour IV + 600 ppm 4-methylimidazole) there was a slight increase in mortality at birth. No teratogenic effects were found (Til & Spanjers, 1973). A range-finding reproduction study was conducted on F344 rats. Five groups of 12 male and 12 female mature rats were given caramel colour IV at concentrations of 0, 10, 15, 20, or 25% in drinking water for 21 days prior to mating and throughout mating, gestation, and lactation. Animals of the F0 generation were killed when animals from the F1 generation were weaned. At weaning, 2 pups/sex/litter were randomly selected from litters that had a minimum of 2 males and 2 females at day 21 and treatment of these animals was continued for 13 weeks post-weaning. Haematology and clinical chemistry were performed on days 45/46 and at termination. Complete gross post-mortem examinations of both F0 and F1 animals were performed at sacrifice. Selected organs (caecum, spleen, thymus, liver, kidneys, heart, adrenals, and gonads from animals of the F0 generation were weighed at autopsy. Although the dose levels of caramel colour IV in this study were very high (ranging from 8-28 g/kg b.w.), no specific toxic effects were observed. All F0-generation animals survived the duration of the study, but 3 F1-generation animals were killed accidentally while sampling for clinical chemistry studies at day 45. In the 20- and 25%-dose groups of both generations there was a higher incidence of soft stools than in the controls, and all animals of the F0 generation showed slight to statistically significant, dose-related decreases in body weight. Dose-related depression of body-weight gain was also noted in animals of the F1 generation. Mating, pregnancy, and fertility rates were comparable for all groups, but the number of implantation sites and of pups alive at days 0, 4, and 21 of lactation in the 20%-dose groups was significantly lower than control values. Litter size was decreased at the 15-, 20- and 25%-dose levels. Pups in the 25%-dose group showed a markedly higher incidence of alopecia and arched spine than controls, and a generalized poor condition during the last 7 days of suckling. No significant haematological changes were observed at 45 or 90 days post-weaning, except that prothrombin time of the F1 females in the 15 and 25% groups were significantly greater than controls at day 45. Blood urea nitrogen values were lower than controls at 45 and 90 days but other clinical chemistry values were normal. At necropsy, dose-related increases in absolute and relative weights of the liver, kidneys, and caecum (full and empty) were observed from animals in the 15%- and higher-dose groups. The only gross treatment-related morphological changes reported were brown/black or green colouration of the contents and mucous membrane of the lower gut and mesenteric lymph nodes (Tierney, 1980). Special studies on teratogenicity Teratogenicity tests were performed with caramel colour IV on mice, rats, and rabbits. The doses employed were 0, 16, 74.3, 345, and 1600 mg/kg b.w. in all 3 species. Mice Caramel colour IV was administered by gavage to groups of 19-22 pregnant albino CD1 mice at the doses above, beginning on day 6 and continuing through day 15 of gestation. Body weights were recorded and all animals were observed daily for changes in appearance and behaviour. On day 17 all dams were subjected to Caesarean section under surgical anaesthesia and the numbers of implantation sites, resorption sites, live and dead foetuses, and body weights of live pups were recorded. All foetuses were examined grossly for external congenital abnormalities, one-third of the foetuses from each litter underwent visceral examination (Wilson technique), and the remaining two-thirds were cleared, stained with Alizarin Red, and examined for skeletal defects. The number of abnormalities seen in either soft or skeletal tissues did not differ from the number occurring spontaneously in sham-treated controls (Morgareidge, 1974). Rats Caramel colour IV was administered by gavage to groups of 21-24 pregnant Wistar rats at the dose levels above, beginning on day 6 and continuing daily through day 15 of gestation. Body weights were recorded and all animals were observed daily for changes in appearance and behaviour. On day 20 dams were subjected to Caesarean section under surgical anaesthesia and the number of implantation sites, resorption sites, live and dead foetuses, and body weights of live pups were recorded. All foetuses were examined for gross, visceral, and skeletal abnormalities as in the mouse experiment. No clearly discernible effects on nidation or on maternal or foetal survival were observed. The number of abnormalities seen in the test groups did not differ from the number occurring spontaneously in sham-treated controls (Morgareidge, 1974). Rabbits Caramel colour IV was administered by gavage to groups of 11-12 pregnant Dutch-belted female rabbits at the doses above beginning on day 6 and continuing daily through day 18 of pregnancy. Body weights were recorded and all animals were observed daily for changes in appearance and behaviour. The does were subjected to Caesarian section under surgical anaesthesia on day 29 and the numbers of corpora lutea, implantation sites, resorption sites, and live and dead foetuses were recorded. Body weights of the live pups were also recorded. All foetuses were examined grossly for the presence of external congenital abnormalities. The live foetuses from each litter were then placed in an incubator for 24 hours for evaluation of neonatal survival. Surviving pups were sacrificed and all pups examined for visceral abnormalities (by dissection). All foetuses were then cleared with potassium hydroxide, stained with Alizarin Red, and examined for skeletal defects. No clearly discernible effects on nidation or on maternal or foetal survival were observed. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in sham-treated controls (Morgareidge, 1974). Special study on haematology Rats A study was conducted in rats to determine whether haematological changes were associated with the feeding of high dietary concentrations of caramel colour IV. Sixty-six male rats, mean initial body weights approximately 173 g, were fed caramel colour IV in the diet for 28 days. Sixteen rats were assigned to a control group and 10 rats/group were assigned to levels of 16 or 22% caramel colour IV (high colour intensity) and 34 or 47% caramel colour IV (low colour intensity). Caramel colour III was fed at a 4% level to a positive control group. The parameters observed were body weight, food consumption, haematology (total and differential leucocyte counts), and terminal necropsy with organ weights (caecum - full and empty). Rats were bled from the retro-orbital sinus on days 16, 9, and 2 before treatment and again on days 7, 14, and 28 during treatment. Feeding of these high dietary levels of caramel colour IV led to reduced rates of body-weight gain. The animals fed caramel colour III gained weight at a rate similar to the controls. Animals receiving caramel colour III had progressively lower relative lymphocyte counts commencing 1 week after treatment and increasing in severity with duration of treatment. This pattern of decreased relative lymphocyte counts was not seen with either sample of caramel colour IV and no significant decreases in lymphocyte counts were observed at any dose level of this caramel colour. Caecal weights were increased in all treatment groups (BIBRA, 1978). Acute toxicity No information available. Short-term studies Mice Groups of 10 B6C3F1 mice of each sex were given concentrations of 0, 10, 15, 20, or 30% caramel colour IV in drinking water for 4 weeks. The intake of caramel colour IV expressed in g/kg b.w./day was more than twice the percentage concentration in the drinking water. At 28 days the body weights of male animals at the 30%-dose level were significantly decreased compared to the controls, and transient depressions of body weights were noted at the highest-dose level in females. No significant depressions in body-weight gain were noted at the lower-dose levels in either male or female mice. Fluid consumption was depressed throughout the study among all treatment groups. However, these changes were not consistent with time or dosage. There were no statistically significant differences in food consumption between treated animals and controls. At necropsy, the only treatment- related effect reported was enlargement of the caecum (Tierney, 1979). Rats Groups of 5 rats received either 10 or 20% caramel colour IV solution (equivalent to about 10 or 20 g/kg b.w./day) as their sole source of fluid for 127 days. Only dark faeces and very mild diarrhoea were noted. No adverse effects were noted regarding general health, body weight, food and fluid consumption, haematology, gross pathology, or histopathology (Haldi & Wynn, 1951). Six groups of 5 male and 5 female weanling rats received 0 or 10% caramel colour IV solution as their sole fluid source for 100, 200, or 300 days. No adverse effects were noted regarding growth, food and fluid intake, haemotology, gross pathology, or histopathology (Haldi & Wynn, 1951). Groups of 16 male and 16 female rats received either 0 or 10% caramel colour IV solution for 100 days and groups of 5 rats received 20% caramel solution for 100 days. At the lower test level, there were no observable abnormalities as regards growth, food consumption, haematology, gross pathology, or histopathology. Only growth and haematology were examined at the higher test level, and the results for both parameters were found to be normal (Haldi & Wynn, 1951). Groups of 5 male and 5 female rats were given 1 ml/kg b.w. of concentrated caramel colour for 21 days. Some diarrhoea was induced in all animals, but no other abnormalities were noted. Gross pathology and histopathology revealed no significant changes due to administration of the test compound (Foote et al., 1958). Three groups of 20 male and female rats received either 0 or 11-14 g/kg b.w. of caramel colour IV solutions for 100 days. Growth and food intake did not differ significantly between test and control animals. Gross pathology and histopathology showed no abnormal findings related to administration of the test compound (Haldi & Wynn, 1958). Four groups of 10 male and 10 female Sprague-Dawley rats received 0, 0.1, 1.0 or 10% caramel colour IV in their diet for 12 weeks. No adverse effects were noted on growth, food consumption, urinalysis, haematology, gross pathology, or histopathology that were related to administration of the caramel colour (Prier, 1960). Groups of 10 male and 10 female rats received 0, 5, or 10 g/kg caramel colour IV in their diet for 3 months. Weight gain was normal in all groups. Food consumption, haematology, and urinalysis were comparable in all groups. Gross pathology and histopathology showed no test-related adverse findings (Chacharonis, 1960). Four groups of 10 male and 10 female Sprague-Dawley rats received 0, 5, 10, or 20% caramel colour IV (low colour intensity) or caramel colour IV (high colour intensity) in their diet for 90 days. In addition, a paired-feeding study involving 5 male rats in 2 groups was run for 23 days (one sample was at the 20% level), and there were no differences in the rate of growth. The only effects attributable to treatment were a mild depression in growth of male rats at the 10 and 20% levels due to unpalatability of the test diet. No other adverse findings were noted in growth, behaviour, mortality, haematology, urinalysis, gross pathology, organ weights, or histopathology (Kay and Calandra, 1962a; 1962b). Four groups of 10 male and 10 female Sprague-Dawley rats received either 0 or 10% of 3 different caramel colours (one of which was a sample of caramel colour IV) in their diet for 90 days. Weight gains showed a slight reduction compared with controls but food consumption was normal for all groups. No abnormalities were noted with regard to haematology, urinalysis, gross pathology, or histopathology (Chacharonis, 1963). Four groups of 15 male and 15 female rats received 0, 5, 10, or 20% caramel colour IV in their diet for 90 days. No adverse effects were noted on appearance, behaviour, survival, body weights, food intake, haematology, blood chemistry, urinalysis, organ weights, gross pathology, or histopathology (Oser, 1963). Four groups of 10 male and 10 female rats received 0, 0.015, 0.3, or 3.0% caramel colour IV in their diet for 90 days. No differences between test and control animals were noted regarding body weight, food consumption, haematology, urinalysis, gross pathology, or histopathology (Nees, 1964). Four groups of rats received 0, 4, 8, or 16% caramel colour IV in their diet for 3 months. No convulsions or other behavioural abnormalities or signs of neurological damage were seen. No macroscopic or microscopic pathological abnormalities were found in the central nervous system (Sharratt, 1971). Three groups of 20 female Wistar rats received stock diet to which 0, 10, or 20% caramel colour IV containing 202 ppm 4- methylimidazole was added. During the second week of the experiment these levels of caramel colour IV were increased to 15 and 25% and in week 7, the levels were increased to 25 and 30% caramel colour IV. The diets were administered for 16 weeks followed by a 4-week recovery period. Food consumption and growth of the test animals were comparable with the controls. Leucocyte counts, collected after 4, 8, 12, and 16 weeks, did not show statistically significant differences among the groups. The relative weights of the caecum, both filled and empty, were distinctly increased after 4 weeks of feeding caramel colour IV. After the recovery period of 4 weeks the increases had disappeared. The relative weight of the thymus was not affected. Gross examination at autopsy after 16 weeks of feeding caramel clour IV revealed a dose-related, brown-greenish discolouration of the mesenteric lymph nodes in all test animals of the highest-dose level. After the recovery period of 4 weeks the colour change was less, but still visible. Microscopically, the lymph nodes of the test rats showed pigment accumulation which was not noticeably diminished after withdrawal of the caramel for 4 weeks. These results failed to confirm the decreased leucocyte counts that were observed in females fed 5 to 15% caramel colour IV in a 1-year feeding study (Sinkeldam & van der Heyden, 1975). A 10-week feeding study with 18 groups of 10 male and 10 female Wistar rats was carried out with 3 caramel colours, including caramel colour IV (low colour intensity) and caramel colour IV (high colour intensity). The dietary concentrations were 0, 1.25, 2.5, 5, 10, and 15% caramel colour IV (low colour intensity) and 0, 0.5, 1, 2, 4, and 6% caramel colour IV (high colour intensity). Both caramel colours caused loose stools at the highest-dose levels, although body-weight gains were not affected. Leucocyte (lymphocyte) counts were not affected in the animals fed samples of caramel colour IV at any of the dose levels. Only slight indications of caecal enlargement were observed. Minimal amounts of pigment were observed in the mesenteric lymph nodes of rats fed 2.5% and higher of the low colour intensity sample, and 1% and higher of the high colour intensity sample (Sinkeldam and van der Heyden, 1976). In a 10-week feeding study, 17 groups of 15 male and 15 female Sprague-Dawley rats were given various caramel colours that included caramel colour IV (low colour intensity) and caramel colour IV (high colour intensity). The dose levels fed were 1.25, 2.5, 5, 10, and 15% for caramel colour IV (low colour intensity) and 0.5, 1, 2, 4, and 6% caramel colour IV (high colour intensity). Two control groups were used. In the animals fed caramel colour IV (low colour intensity) at the 15% level, the faeces became soft within 2 weeks. The water content of the faeces from these animals was higher than that of the controls, as was the water content of faeces from rats fed 6% caramel colour IV (high colour intensity). Body-weight gains were slightly decreased in male, but not female, rats fed both samples of caramel colour. There were no significant changes in total white cell or lymphocyte counts in animals fed either sample of caramel colour IV. No macroscopic or microscopic evidence of abnormal pigmentation of the mesenteric lymph nodes was found in any group of either sample of caramel colour IV. Caecal weights were generally increased in all test groups fed both samples of caramel colour IV (Procter et al., 1976). Groups of weanling Wistar rats were given caramel colour IV (low colour intensity) or caramel colour IV (high colour intensity) at concentrations of 0, 0.5, 1.0, 2.0, 4.0, or 16.0% in the diet for 10 weeks. Each group contained 15 male or 15 female rats except the control group (60 animals of each sex) and the 16%-dose group (10 animals of each sex). Food intake and growth were recorded and haematological studies were carried out. Lymph nodes, thymus, spleen, and caecum were examined histologically for distribution of pigment. An additional 3 groups of 10 rats of each sex were given basal diet or diet containing 16% each of the caramel colours for 10 weeks. At the end of this period all the rats received basal diets. Haematological studies were performed on these animals at 3, 7, 14, and 28 days. Five rats of each sex were killed after 7 days and the remainder after 28 days of feeding basal diet (recovery experiment). Decreased body-weight gains were noted in animals of both sexes fed 16% caramel colour IV (high colour intensity). No decreases were observed in the groups fed caramel colour IV (low colour intensity). Food intake was not consistently altered in any of the groups fed either sample of caramel colour IV. Occasionally, values for total leucocyte counts were significantly higher or lower than controls in the groups fed both samples of caramel colour IV; however, these changes were not consistent in direction and they were not dose- related. There were no consistent or dose-related differences in lymphocyte counts between the groups fed caramel colour IV and the controls. Liver weights were significantly increased in the group fed 16% caramel colour IV (high colour intensity). Increased relative kidney weights were observed in the groups fed 2, 4, and 16% caramel colour IV (high colour intensity) and 16% caramel colour IV (low colour intensity), although no histological changes were observed. Increased caecal weights were seen only at the 16% feeding level for both caramel colours. At necropsy pigmentation of the lymph nodes was seen at the 16% feeding level of both caramel colours. Microscopically, pigmentation was observed in the mesenteric lymph nodes in the males and females in the groups fed 16% caramel colour IV (high colour intensity). Relative weights of the liver and kidneys and caecal weights returned to normal during the recovery period (BIBRA, 1977). Five groups of 30 male and 30 female weanling F344 rats were given caramel colour IV in drinking water at concentrations which provided intakes of 0, 15, 20, 25, or 30 g/kg b.w./day for 13 weeks. After 43 days, 10 animals of each sex from each group were randomly selected for collection of data on urinalysis, haematology, and clinical chemistry, followed by sacrifice and necropsy; similar examinations were performed on survivors at termination. At interim and terminal sacrifice, a detailed necropsy was performed on all animals and a complete histopathological examination was performed on controls and animals in the top-dose group. Throughout the study, rats given caramel colour IV produced dark- coloured, soft or sticky, liquid and/or odorous, faeces which stained and caused alopecia of the perianal area, most noticeably at the higher-dose levels. Dose-related decreases in food intake, water consumption (after correction for caramel content), and body-weight gains were observed and were attributed to the poor palatability of the drinking solutions. Caramel colour IV at the dose levels tested did not significantly affect haematological values at interim or terminal examinations. All treatment groups of both sexes had significantly-reduced blood urea nitrogen and alkaline phosphatase levels at both 45 and 90 days. Total serum protein values of both sexes in the treatment groups were lower than controls at 90, but not at 45, days. These effects may be due to reduced food intake and growth retardation. Treated rats had reduced urine volume and increased urine specific gravity, protein, ketones, and acidity, which were associated with decreased water consumption. Increased kidney weights were observed at necropsy. Treatment-related decreases in thymus and spleen weights and increased caecal size, with staining of the mucosa of the caecum and colon, were noted. Accumulation of yellowish-tan pigment occurred in macrophages of the mesenteric lymph nodes. No treatment- related histopathological changes were observed in any organs at the highest-dose level (Heidt & Rao, 1980). A 1-year rat toxicity study was conducted as a continuation of the reproduction study described earlier (Til & Spanjers, 1973). It involved the interim sacrifice of one-fourth of the animals utilized in the 2-year toxicity study described below. Wistar rats (10 males or 10 females in each group) were selected from the first litter of parents that were given diets containing 6 samples of caramel colour IV, 3 of which were low colour intensity and 3 of which were high colour intensity. The dose levels employed were 5, 10, and 15% caramel colour IV (low colour intensity) and 2, 4, and 6% caramel colour IV (high colour intensity). Two additional samples of caramel colour IV (low colour intensity) were tested at 10% and 2 additional samples of caramel colour IV (high colour intensity) were tested at 4% in the diet. The animals were sacrificed after a feeding period of 1 year. No adverse effects on behaviour, growth, food intake, mortality, liver and kidney function tests, urine composition, or organ weights were observed. Haematological indices showed a slight dose-related decrease in total leucocyte counts in females fed one sample of caramel colour IV (low colour intensity) which contained 202 mg/kg methylimidazole. In males, no effect was noted and in a subsequent experiment in which the same sample of caramel colour IV was fed to female rats at levels as high as 15 and 30%, no indications of decreased leucocyte counts were observed after 4, 8, 12, or 16 weeks. The only finding attributed to the feeding of caramel colour IV consisted of increased accumulation of a yellow-brown pigment and pigment-laden macrophages in the mesenteric lymph nodes of males and females in all caramel colour IV groups. Inflammatory or degenerative changes of the lymphoid tissue were not found (Sinkeldam et al., 1975). Dogs Four groups of 3 male and 3 female adult beagle dogs received 0, 6, 12.5, or 25% caramel colour IV in their diet 5 days per week for 90 days. No significant adverse effects on growth, behaviour, food consumption, mortality, liver function, kidney function, haematology, urinalysis, gross pathology, or histopathology were noted (Kay and Calandra, 1962c). Long-term toxicity studies Rats Six samples of caramel colour were tested in a long-term toxicity study, 3 of which were caramel colour IV (low colour intensity) and 3 of which were caramel colour IV (high colour intensity). Each group consisted of 40 male or 40 female weanling Wistar rats, except the control group which had double this number of animals. Animals were selected from the first litter of parents fed diets containing the various caramel colours from weaning age (see reproduction studies, Til & Spanjers, 1973). The dose levels tested were 5, 10, or 15% caramel colour IV (low colour intensity) and 2, 4, or 6% caramel colour IV (high colour intensity). Two additional samples of caramel colour IV (low colour intensity) were tested at 10% and 2 additional samples of caramel colour IV (high colour intensity) were tested at 4% in the stock diet. Observations were made of general appearance, behaviour, mortality, growth, food intake, haematological factors, and clinical chemistry of blood and urine. After about 14 months mortality attributed to intercurrent disease was observed in both control and treated groups. Approximately three-quarters of the animals died or were killed before the experiment was terminated at week 104. Organs of animals that died or were killed were weighed and extensive histopathological examinations were carried out. However, one-third of the animals could not be examined histopathologically due to autolysis. At week 104 organs were weighed and extensive histopathological examinations were carried out on all surviving rats of all groups. No clinical changes were observed in this study except for slightly decreased haemoglobin and haematocrit values at weeks 78 and 98 in males fed caramel colour IV (high colour intensity). Leucocyte counts were decreased in females fed 10 and 15% of one sample of caramel colour IV (low colour intensity) at weeks 13 and 52, but these changes were not consistent and decreases in lymphocyte counts were not reported. At autopsy, an increased incidence of greenish discoloured mesenteric lymph nodes was observed in most groups fed high levels of caramel colour. Microscopically, an increased pigment- phagocytosis in the mesenteric lymph nodes in all test groups (except the group fed 2% caramel colour IV (high colour intensity)) was observed. No evidence of any other adverse structural or cellular alteration was found. Gross and microscopic examination of the other organs did not reveal any pathological changes attributable to the ingestion of caramel colour IV. An increase in the incidence of neoplastic lesions in the different groups was not found (Sinkeldam et al., 1976). A long-term toxicity and carcinogenicity study of caramel colour IV was conducted using F344 rats (MacKenzie, 1985a). Details are given above (see special studies on carcinogenicity). Observations in man Tolerance studies of caramel colour IV (low colour intensity) and caramel colour IV (high colour intensity) were conducted in human volunteers. The subjects, 10 men and 10 women, ingested caramel colour once daily in simulated soft drinks over 3 test periods of 21 days each separated by 7-day rest intervals. The test doses were 6 g/day during the first test period, 12 g/day during the second period, and 18 g/day during the third test period. Haematological, clinical chemical, and routine urinary parameters were studied at the beginning of each ingestion period, after 10 days of ingestion, and at the end of each ingestion period. Most individual values for haemoglobin, haemotocrit, RBC, corrected sedimentation rate, WBC, and differentials (neutrophils, basophils, eosinophils, monocytes, and lymphocytes) were found to be within normal limits. There were a few instances of values outside the normal range, indicating mild neutropenia and mild lymphocytosis, but these were not consistent and were unrelated to the ingestion of caramel colour IV. On the other hand, caramel ingestion was associated with an increased frequency of bowel movements and softening or increased liquidity of faeces (Marier et al., 1977a; 1977b). Comments The pigmentation of mesenteric lymph nodes and caecal enlargement were considered to be non-specific effects that are of no toxicological significance. The carcinogenicity studies required by the twenty-fourth meeting of the Committee (Annex 1, reference 53) have been conducted in rats and mice, and no treatment-related neoplastic changes were observed. The material used in these studies conformed to recent specifications. The committee based its evaluation on the no-effect level in these long-term/carcinogenicity studies, to which (in view of the ancillary human data in which no adverse effects other than laxation were observed) a safety factor of 50 was applied. EVALUATION Level causing no toxicological effect Mouse: 10 g/kg b.w./day in drinking water Rat: 10 g/kg b.w./day in drinking water Man: No adverse effects other than laxation at levels up to 18 g/day. Estimate of acceptable daily intake for man 0-200 mg/kg b.w. (0-150 mg/kg b.w. on a solids basis). REFERENCES Ashoor, S.H. & Monte, W.C. (1983). Mutagenicity of commercial caramels. Cancer Letters 18, 187-190. BIBRA (1977). The short-term (10 week) feeding study with three caramels in rats. Unpublished report No. 177/2/77 from the British Industrial Biological Research Association, Carshalton, Surrey, England. BIBRA (1978). The evaluation of the effect of sulfite ammonia caramels on the lymphocytes of the rat. Unpublished report No. 238/2/78 from the British Industrial Biological Research Association, Carshalton, Surrey, England. Brusick, D. (1974). Mutagenic evaluation of compound FDA 71-83, caramel. Unpublished report No. 2468 from Litton Bionetics Inc., Kensington, MD, USA. Chacharonis, P. (1960). Acute and chronic toxicity studies on caramel colours A and B. Unpublished report No. S.A. 54219 from Scientific Associates Inc., St. Louis, MO, USA. Chacharonis, P. (1963). Acute oral toxicity study in rats on caramel colorings 25A-1, 30B-0, and 30F-1. Unpublished report No. S.A. 79105 from Scientific Associates Inc., St. Louis, MO, USA. Foote, W.L., Robinson, R.F., & Davidson, R.S. (1958). Toxicity of caramel color products. Unpublished report of Battelle Memorial Institute, Columbus, OH, USA. Galloway, S.M. & Brusick, D.J. (1981a). Mutagenicity evaluation of ETA-36-1 in an in vitro cytogenetic assay measuring chromosome aberration frequencies in Chinese hamster ovary (CHO) cells. Unpublished report No. 20990 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Galloway, S.M. & Brusick, D.J. (1981b). Mutagenicity evaluation of ETA-63-1S in an in vitro cytogenetic assay measuring chromosome aberration frequencies in Chinese hamster ovary (CHO) cells. Part II. Unpublished report No. 20990 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Haldi, J. & Wynn, W. (1951). A study to determine whether or not caramel has any harmful physiological effect. I. Unpublished report from Emory University, Atlanta, GA, USA. Haldi, J. & Wynn, W. (1958). A study to determine whether or not caramel has any harmful physiological effect. II. Unpublished report from Emory University, Atlanta, GA, USA. Heidt, M. & Rao, G.N. (1980). 90-day subacute toxicity study of caramel color (sulfite ammonia process) type SAC2 in rats. Unpublished report No. 79028 from Raltech Scientific Services, Inc., Madison, WI, USA. Submitted to WHO by International Technical Caramel Association. Ishidate, M. Jr. & Yoshikawa, K. (1980). Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation - a comparative study on mutagens and carcinogens. Arch. Toxicol. Suppl. 4, 41-44. Jagannath, D.R. & Brusick, D. (1978a). Mutagenicity evaluation of ETA 4-10, ETA 4-11, ETA 4-15 in the Ames Salmonella/microsome plate test. Unpublished report No. 20838 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Jagannath, D.R. & Brusick, D. (1978b). Mutagenicity evaluation of caramel colors ETA 4-8, ETA 4-9, ETA 4-12, ETA 4-13, ETA 4-14 in the Ames Salmonella/microsome plate test. Unpublished report No. 20838 from Litton Bionetics Inc., Kensington, MD, USA. Submitted to WHO by International Technical Caramel Association. Kawachi, T., Yahagi, T., Kada, T., Tazima, Y., Ishidate, M., Sasaki, M., & Sugiyama, T. (1980). Cooperative programme on short-term assays for carcinogenicity in Japan. In Molecular and Cellular Aspects of Carcinogen Screening Tests, IARC Scientific Publication No. 27, 323-330. International Agency for Research on Cancer, Lyon, France. Kawana, K., Akema, R., Nakaoka, T., Ikeda, H., Takimoto, T., & Kawauchi, S. (1980). Studies on mutagenicities of natural food additives. II. Mutagenicities and antibacterial activities of caramels. Eisei Kagaku 26, 259-263. Kay, J.H. & Calandra, J.C. (1962a). Subacute oral toxicity of caramel colorings (coded Sample A) - albino rats. Unpublished report from Industrial Bio-test Laboratories, Inc., Northbrook, IL, USA. Kay, J.H. & Calandra, J.C. (1962b). Ninety-day subacute oral toxicity of caramel coloring (coded Sample B) - albino rats. Unpublished report from Industrial Bio-test Laboratories, Inc., Northbrook, IL, USA. Kay, J.H. & Calandra, J.C. (1962c). Subacute oral toxicity of caramel coloring (coded Sample A) - dogs. Unpublished report from Industrial Bio-test Laboratories, Inc., Northbrook, IL, USA. MacKenzie, K.M. (1985a). Carcinogenicity and chronic toxicity study of caramel color (sulfite ammonia process) type SAC2 in rats (Chronic toxicity portion, Vols. I-V; Carcinogenicity portion, Vols. I-VIII). Unpublished study No. 81184 from Hazleton Laboratories America, Inc., Madison, WI, USA. Submitted to WHO by International Technical Caramel Association. MacKenzie, K.M. (1985b). Carcinogenicity study of caramel color (sulfite ammonia process) type SAC2 in mice. Vols. I-VI. Unpublished study No. 81185 from Hazleton Laboratories America, Inc., Madison, WI, USA. Submitted to WHO by International Technical Caramel Association. Marier, G., Berry, G., & Orr, J.M. (1977a) Tolerance study of single strength ammonia sulfite caramel in human volunteers. Unpublished project No. 5612, report No. 2, from Bio-Research Laboratories Ltd., Pointe Claire, Quebec, Canada. Marier, G., Berry, G., & Orr, J.M. (1977b) Tolerance study of double strength ammonia sulfite caramel in human volunteers. Unpublished project No. 5711, report No. 2, from Bio-Research Laboratories Ltd., Pointe Claire, Quebec, Canada. Morgareidge, K. (1974). Teratologic evaluation of FDA 71-83 (caramel, beverage) in mice, rats and rabbits. Unpublished report No. PB 234-867 from Food and Drug Research Laboratories Inc., Waverly, NY, USA. Nees, P.O. (1964). Toxicological feeding study of caramel E. Unpublished report from Wisconsin Alumni Research Foundation, Madison, WI, USA. Oser, B.L. (1963). Toxicological feeding study of "acid-proof" caramel. Unpublished report No. 83911 from Food and Drug Research Laboratories, Inc., Waverly, NY, USA. Prier, R.F. (1960). The toxicity of double strength acid proof caramel in rats - 12 week feeding test. Unpublished report No. 9070599 from Wisconsin Alumni Research Foundation, Madison, WI, USA. Procter, B.G., Berry, G., & Chappel, C.I. (1976). A toxicological evaluation of various caramels fed to albino rats. Unpublished report No. 4244 from Bio-Research Laboratories Ltd., Pointe Claire, Quebec, Canada. Selim, S. (1982). Single and repeat oral dose pharmacokinetic and distribution studies of caramel color concentrate in the rat. Unpublished study No. IT-59r from Primate Research Institute, Holloman Air Force Base, NM, USA. Submitted to WHO by International Technical Caramel Association. Sharratt, M. (1971). Unpublished report. Sinkeldam, E.J. & van der Heyden, C.A. (1975). Short-term feeding study with caramel SS 202 in albino rats. Unpublished report No. R 4777 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Sinkeldam, E.J. & van der Heyden, C.A. (1976). Short-term (10 week) feeding study in rats with three different ammonia caramels. Unpublished report No. R 5120 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Sinkeldam, E.J., van der Heyden, C.A., & Beems, R.B. (1976). Chronic (two year) feeding study in rats with six different ammonia caramels. Unpublished report No. R 4961 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Sinkeldam, E.J., Willems, M.I., & van der Heyden, C.A. (1975). One year feeding study in rats with six different ammonia caramels. Unpublished report No. R 4767 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Tierney, W.J. (1979). A four-week dose range-finding study of caramel colour no. 3, sample 3-1, in mice. Unpublished project No. 79-2380 from Bio/dynamics Inc., East Millstone, NJ, USA. Submitted to WHO by International Technical Caramel Association. Tierney, W.J. (1980). An in-utero range-finding study of caramel colour no. 3, sample 3-1, in rats. Unpublished project No. 79-2405 from Bio/ynamics Inc., East Millstone, NJ, USA. Submitted to WHO by International Technical Caramel Association. Til, H.P. & Spanjers, M. (1973). Reproduction study in rats with six different ammonia caramels. Unpublished report No. R 4068 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands.
See Also: Toxicological Abbreviations